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Abstract
Characterization of the Airway Epithelial Bioelectric Mechanisms Associated with the
Effects of Epithelium-Derived Relaxing Factor in Guinea-Pig Isolated Trachea
Richard A. Johnston
In response to elevated serosal or mucosal tonicity, guinea-pig tracheal epithelium
releases the non-nitric oxide, non-prostanoid, epithelium-derived relaxing factor (EpDRF), which
subsequently diffuses to the underlying airway smooth muscle to initiate relaxation.
Hypertonicity-induced smooth muscle relaxation via EpDRF involves epithelial Na+ and Cl!
channels and is preceded by a depolarization of the transepithelial potential difference (Vms). By
utilizing two different experimental systems, this study sought to characterize further the airway
epithelial bioelectric mechanisms associated with the effects of EpDRF in guinea-pig isolated
trachea.
First, this study attempted to elucidate which epithelial ion channels and/or transporters
are involved in the depolarization of the Vms. This was accomplished by determining the effect
of ion channel and transporter inhibitors on in vitro transepithelial short-circuit current responses
to elevated mucosal tonicity in guinea-pig tracheal segments mounted in Ussing chambers. The
data from these studies indicate that apical Na+ channels and the basolateral Na+-K+-2Cl!
cotransporter are intimately involved in the epithelial bioelectric response to elevated mucosal
tonicity, and thus, may play an important role in the synthesis, release, and/or effects of EpDRF.
Secondly, this study sought to determine the consequences of altered epithelial ion
transport, following LPS-treatment (4 mg/kg, i.p.; 18 hr post-treatment), on EpDRF-induced
smooth muscle relaxation and its associated bioelectric events as well as airway reactivity to
methacholine (MCh). In vitro tracheal smooth muscle contractile and relaxant responses as well
as Vms responses were measured utilizing the isolated and modified isolated, perfused trachea
apparatuses while the two-chambered, whole-body plethysmograph was used to measure in vivo
airway reactivity. LPS-treatment caused numerous and complex changes in EpDRF-induced
smooth muscle relaxation and its associated bioelectric events. In addition, LPS-treatment
causes in vivo airway hyporeactivity to MCh. These results suggest that the effects of EpDRF on
smooth muscle reactivity are modulated by changes in the electrical activity of the epithelium
which can ultimately impact on airway reactivity to MCh.
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Introduction
The Mammalian Respiratory System
The mammalian respiratory system is comprised of the lungs, the extra- and
intrapulmonary airways, the chest wall, and the respiratory control centers of the central nervous
system (Levitzky, 1995). The primary function of the respiratory system is to exchange gases
between the atmosphere and the blood. This ensures that mammals are supplied with oxygen
while carbon dioxide is removed (West, 1995; Johnson, 1997). Oxygen, in conjunction with
other organic molecules, is utilized by the cell to produce energy in the form of adenosine
triphosphate during the process of oxidative phosphorylation (Lehninger et al., 1993). Aside
from gas exchange, the respiratory system has non-respiratory functions which include playing a
significant role in (1) acid-base balance, (2) body defense, (3) metabolism, (4) olfaction, (5)
phonation, and (6) water loss (Levitzky, 1995).
In order for cells to be supplied with oxygen, the oxygen within the inspired air must first
gain access to the alveoli, or gas exchanging regions of the lung, before being distributed
throughout the body by means of the circulatory system. Air is primarily inspired through the
nose and to a lesser extent, the mouth, and once inspired, it passes through the pharynx, larynx,
trachea, bronchi, and bronchioles until it eventually reaches the alveoli. The most distal portion
of the trachea branches into right and left primary bronchi which enter the right and left lungs,
respectively. The right and left primary bronchi continue to branch even further into at least two
smaller daughter branches. The airways continue to branch until terminating into alveolar sacs
(Weibel, 1963; Nagaishi et al., 1972; Curtis and Barnes, 1989; Sherwood, 1997). Figure 1
illustrates the branching of the tracheobronchial tree, and because of anatomical and functional
differences along its length, it is divided into a conducting zone and a respiratory or transitional
zone. The conducting zone consists of airway generations zero to sixteen while generations
seventeen to twenty-three make up the respiratory or transitional zone (Weibel, 1963).
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Gas exchange is restricted to the respiratory or transitional zone while the conducting
zone constitutes an anatomic dead space (Levitzky, 1995). When air moves through the
conducting airways, it is humidified and warmed to body temperature
(Levitzky, 1995; Sherwood, 1997). The respiratory or transitional zone occupies the last 5 mm
of each airway branch and consists of small airways, namely bronchioles and alveoli, which are
capable of gas exchange (Bouhuys, 1977). In addition to the functional differences between the
conducting and respiratory or transitional zones, there is also a great deal of structural
heterogeneity in the airways within and between these two regions.
The airways of the upper conducting zone are relatively nonmuscular, rigid tubes
encircled by cartilaginous rings. Their walls are rich in connective tissue and cartilage but
sparsely populated with smooth muscle (Johnson, 1997). The luminal surface of these airways
are predominately lined with ciliated, pseduostratified, columnar epithelial cells, among which
are dispersed submucosal glands, basal, brush, goblet, Kulchitsky, and serous cells as well as a
small number of neuroendocrine cells
(Divertie and Brass, 1980; Fawcett and Jensh, 1997; Johnson, 1997).
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Figure 1. Divisions of the tracheobronchial tree. Z, generation; BR, bronchus; BL, bronchiole;
TBL, terminal bronchiole; RBL, respiratory bronchiole; AD, alveolar duct; AS, alveolar sac.
Reprinted with permission from Weibel ER (1963) Morphometry of the Human Lung, Academic
Press Ltd, London UK.
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The airways located at the junction between the conducting and respiratory or transitional zones
differ from those either proximal or distal to them. Their walls are devoid of cartilage and
contain little connective tissue but are rich in smooth muscle (Weibel, 1963; Nagaishi et al.,
1972; Johnson, 1997). Ciliated, cuboidal epithelial cells are the predominant epithelial cell type
of this region; however, they are smaller than their more proximal counterparts. There are fewer
goblet cells in this region while submucosal glands are virtually absent. Clara cells, secretory
cells of ambiguous function, also populate this region
(Divertie and Brass, 1980; Fawcett and Jensh, 1997; Johnson, 1997). The differences in
epithelial cell morphology within the conducting zone are shown in Figure 2.
The airway walls of the respiratory or transitional zone lack smooth muscle and contain
very little connective tissue (Johnson, 1997). Type I alveolar epithelial cells are the predominant
cell type covering the luminal surface of the alveoli. They are long, thin cells lacking cilia.
Type II alveolar epithelial cells, which synthesize and secrete surfactant, are also found, to a
lesser extent, along the luminal surface of the alveoli (Sherwood, 1997). In order for gas
exchange to occur between the alveoli and the blood in the pulmonary capillaries, the gas must
diffuse through the air-blood barrier which is formed by the pulmonary capillary endothelium,
the type I alveolar epithelium, and the interstitial space between the two (Sherwood, 1997). An
illustration of the air-blood barrier is shown in Figure 3. There are an estimated 300 million
alveoli and nearly 1000 pulmonary capillaries surrounding each alveolus, providing a 50-100 m2
surface area for gas exchange (Divertie and Brass, 1980; West, 1995). When this is taken with
the fact that the air-blood barrier is only 0.5 µm thick, the mammalian respiratory system is
indeed an exquisitely efficient gas exchanger (West, 1995; Sherwood, 1997).
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Figure 2. Epithelial cell morphology of the (A) proximal and (B) distal airways of the
conducting zone. Along the respiratory tract, there are distinct differences in epithelial cell
morphology. Copyright 1980. Novartis. Reprinted with permission from Novartis Medical
Education, illustrated by Frank H. Netter, MD. All rights reserved.
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Figure 3. The air-blood barrier. This illustration depicts two of an estimated 300 million
alveoli, the gas exchanging regions of the lung, and the other, affiliated structures of the airblood barrier. Copyright 1980. Novartis. Reprinted with permission from Novartis Medical
Education, illustrated by Frank H. Netter, MD. All rights reserved.

6

The Respiratory Smooth Muscle and Its Neural Innervation
The respiratory or airway smooth muscle is one of the six basic types of smooth muscle
(Horowitz et al., 1996). It has many structural features in common with the other types of
smooth muscle and is found from the trachea to the respiratory bronchioles, albeit in different
quantities.
The parasympathetic nervous system has a profound impact on airway smooth muscle
contraction. Postganglionic parasympathetic fibers directly innervate the smooth muscle. The
release of acetylcholine (ACh) from these neurons initiates smooth muscle contraction via
smooth muscle M3 cholinoceptors which are coupled to Gq-proteins on the muscle cells. Other
spasmogens, by binding to their appropriate receptors, also initiate smooth muscle contraction
through the activation of Gq-proteins. The "q subunit of the Gq-protein activates the inner,
plasma membrane-bound enzyme phospholipase C-$, leading to the synthesis of inositol 1,4,5trisphosphate (IP3) and diacylglycerol from a membrane-bound phospholipid,
phosphatidylinositol 4,5 bisphosphate. IP3 elevates cytosolic Ca2+ levels by stimulating, either
directly or indirectly, the release of Ca2+ from intracellular stores (sarcoplasmic reticulum and
mitochondria), the influx of extracellular Ca2+ through Ca2+-selective ion channels and/or
transporters, and Ca2+-induced Ca2+ release. Elevations in cytosolic Ca2+ activate the
Ca2+/calmodulin-dependent myosin light chain kinase which enhances actin-myosin interactions
resulting in smooth muscle contraction (Figure 4A) (Gross, 1988; Allen and Walsh, 1994;
Horowitz et al., 1996; Janssen et al., 1998).
The sympathetic nervous system can also influence airway smooth muscle tone. There is
evidence that postganglionic sympathetic fibers terminate on postganglionic parasympathetic
nerves, thereby having the capability to modulate cholinergic neural mechanisms
(Ind and Barnes, 1988). Activation of smooth muscle $2-adrenoceptors by adrenergic agonists
initiates bronchodilation by activating adenylate cyclase which increases intracellular cyclic
adenosine monophosphate (cAMP) levels. cAMP stimulates smooth muscle relaxation by down-
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regulating myosin light chain kinase activity, stimulating the uptake of Ca2+ into the
sarcoplasmic reticulum, and activating Ca2+-dependent K+ channels (Figure 4B)
(Kotlikoff and Kamm, 1996; Janssen et al., 1998). In humans, prostaglandin E2 is capable of
elevating intracellular smooth muscle cAMP concentrations and initiating relaxation. "Adrenoceptors are also present on airway smooth muscle, but the consequences of their
activation are more controversial (Ind and Barnes, 1988).
Besides the autonomic nervous system, there are other neural systems capable of
modulating airway smooth muscle tone. The inhibitory nonadrenergic, noncholinergic (iNANC) system is the only significant bronchodilator pathway in humans. Vasoactive intestinal
peptide (VIP) and nitric oxide (NO) are the major neurotransmitters of this system
(Barnes, 1988). VIP exerts its bronchodilating effects by elevating intracellular cAMP levels
while NO initiates bronchodilation by activating soluble guanylate cyclase, resulting in the
activation of smooth muscle K+ channels via cyclic guanosine monophosphate (cGMP) (Figure
4B) (Janssen et al., 1998). The excitatory nonadrenergic, noncholinergic (e-NANC) system is
another neural system capable of influencing airway smooth muscle tone. e-NANC fibers
release substance P and tachykinins from their terminals located beneath the airway epithelium.
Both substance P and tachykinins initiate smooth muscle contraction by activation of their
respective Gq-protein-coupled receptors (Barnes, 1988; Janssen et al., 1998).

8

Figure 4. Mechanisms of airway smooth muscle (A) contraction and (B) relaxation. See text for
details. ACh, acetylcholine; G, G-protein-coupled receptor; PLC, phospholipase C-$; IP3,
inositol 1,4,5-trisphosphate; )V, change in membrane potential: (A) depolarization and
(B) hyperpolarization; NE, norepinephrine; PGE2, prostaglandin E2; NO, nitric oxide; AC,
adenylate cyclase; GC, soluble guanylate cyclase; cAMP, cyclic adenosine monophosphate;
cGMP, cyclic guanosine monophosphate. Reprinted with permission from Janssen LJ, Daniel
EE and Rodger IW (1998) Airway smooth muscle cells: Structure and function, in Asthma:
Basic Mechanisms and Clinical Management (Barnes PJ, Rodger IW and Thomson NC eds) pp
90-112, Academic Press Ltd, London UK.
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The Respiratory Epithelium
The respiratory or airway epithelium constitutes a barrier to control the movement of
substances between the external and internal environments of the body
(Hulsmann and Jongste, 1996; Fawcett and Jensh, 1997); however, the epithelium functions as
more than just a simple diffusion barrier (Widdicombe, 1991; Folkerts and Nijkamp, 1998).
Under normal physiological conditions, the respiratory epithelium also functions as a mucus
transporter (Widdicombe, 1991; Clarke and Boucher, 1993), a regulator of ion and fluid transport
(Clarke and Boucher, 1993; Boucher, 1999), an osmotic sensor
(Willumsen et al., 1994; Dortch-Carnes et al., 1999; Fedan et al., 1999), a site of metabolism for
both endogenous and exogenous substances, and a source of spasmogenic and relaxant
substances which are capable of modulating the reactivity of the underlying airway smooth
muscle
(Flavahan et al., 1985; Fedan et al., 1988; Goldie and Hay, 1997; Folkerts and Nijkamp, 1998).
Overlying the luminal or mucosal surface of the respiratory epithelium is the airway
surface liquid (ASL) which consists of two layers: the sol and the gel. The sol layer is a thin, 5
to 7 µm in depth, watery layer which blankets the surface. Its thickness approximates the length
of the cilia extending from the luminal surface of the epithelium. The gel layer rests upon the sol
layer and is a discontinuous mucus blanket, consisting of 95% water (Figure 5). Since the mucus
is both elastic and viscous, it can easily trap, and subsequently hold, inhaled, foreign matter. As
the cilia beats, both the sol and gel layers move in tandem in a cephalad direction which allows
for the effective clearance of inhaled, foreign substances and microorganisms from the
respiratory tract. Epithelial ion and fluid transport play a major role in determining the depth of
the ASL (Clarke and Boucher, 1993; Widdicombe and Widdicombe, 1995; Boucher, 1999).
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Figure 5. Airway surface liquid (ASL). The ASL blankets the mucosal surface of the airway
epithelium and consists of two layers: the sol and the gel. The depth of the ASL ranges between
5-100 µm (Widdicombe and Widdicombe, 1995). Reprinted from Clarke LL and Boucher RC
(1993) Ion and water transport across airway epithelia, in Pharmacology of the Respiratory
Tract: Experimental and Clinical Research (Chung KF and Barnes PJ eds) pp 505-550 by
courtesy of Marcel Dekker Inc. For clarity, the author of this dissertation added the figure labels.
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Under normal, physiological conditions, the epithelium of the conducting airways of
most mammalian species, excluding the cow and the dog, is Na+-absorbing (Boucher et al., 1982;
Langridge-Smith et al., 1984); however, all generate a lumen-negative potential with respect to
the basolateral surface. A tentative localization of airway epithelial ion channels and transporters
is shown in Figure 6. The activity of the Na+-K+-ATPase, localized to the basolateral surface of
the epithelial cell, establishes an electrochemical gradient which draws Na+ into the cell from the
ASL through amiloride-sensitive Na+ channels. The Na+ is then extruded from the cell across
the basolateral membrane by means of the Na+-K+-ATPase. K+ channels and the electroneutral
Na+-K+-2Cl! cotransporter also play a role in epithelial ion transport. Under normal,
physiological conditions for most mammalian species, there is no net transcellular movement of
Cl!; however, in order to achieve electrochemical equilibrium, Cl! moves through the
paracellular pathway as Na+ is absorbed transcellularly (Figure 6)
(Boucher et al., 1982; Clarke and Boucher, 1993; Knowles et al., 1995).

Epithelium-Derived Relaxing Factor
The respiratory epithelium can synthesize and release substances which are capable of
diffusing to the underlying airway smooth muscle and modulating its tone
(Fedan et al., 1988; Morrison et al., 1990; Hulsmann and Jongste, 1996). These autacoids can
have either an excitatory or inhibitory effect upon airway smooth muscle tone. The inhibitory,
non-nitric oxide, non-prostanoid epithelium-derived relaxing factor (EpDRF) is one such
autacoid (Munakata et al., 1988, 1990; Fedan et al., 1999).
In 1985 Flavahan and colleagues provided the first evidence that the respiratory
epithelium could modulate the tone of the underlying airway smooth muscle. After mechanical
removal of the epithelium from canine bronchial rings, the bronchial smooth muscle became
more sensitive to the effects of contractile agonists (ACh, histamine, and 5-hydroxytryptamine).
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Figure 6. Distribution of airway epithelial ion channels and transporters and the major ion
transport processes of the airway epithelium. This illustration holds true for most mammalian
species (Boucher et al., 1982; Clarke and Boucher, 1993). The various ion channels and
transporters of the airway epithelium are asymmetrically distributed between the apical and
basolateral surfaces of these cells. The respective inhibitor of each ion channel and transporter is
shown in parentheses. The arrows indicate the net, transcellular movement of Na+ and the
passive, paracellular movement of Cl! (illustration produced by and courtesy of Jeffrey S. Fedan,
Ph.D.).
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In canine bronchial rings precontracted with ACh, isoproterenol-induced relaxations were
attenuated in epithelium-denuded preparations. This same study also demonstrated that
contractile responses to transmural nerve stimulation were potentiated by epithelium removal. In
epithelium-intact preparations, the peak contraction elicited by a particular electrical frequency
was followed by a decrease in tone as the stimulation continued; however, this decrease in tone
was absent in epithelium-denuded preparations (Flavahan et al., 1985). Later that same year, a
separate group reported that epithelium removal increased the sensitivity of bovine tracheal strips
to the contractile effects of ACh, histamine, and 5-hydroxytryptamine (Barnes et al., 1985). In
the months and years that followed, other studies with isolated, human (Raeburn et al., 1986a),
guinea pig (Hay et al., 1986; Holroyde, 1986; Murlas, 1986), and rabbit (Raeburn et al., 1986b)
airway preparations reported that epithelium removal increased the sensitivity of the airway
smooth muscle to contractile agonists; however, the effect of epithelium removal upon airway
smooth muscle reactivity to relaxant agonists was much more variable. Most of these studies,
with the exception of Holroyde (1986) concluded that the increased sensitivity of the smooth
muscle to contractile agonists following epithelium removal was due to the loss of an epitheliumderived inhibitory factor, EpDRF, which normally inhibits smooth muscle reactivity to
contractile agonists. Some of these same studies also demonstrated that EpDRF was not a
metabolite of arachidonic acid (Barnes et al., 1985; Flavahan et al., 1985), but nevertheless, a
separate study concluded that the cytochrome P450 enzyme system was involved in epithelial
modulation of smooth muscle tone (Raeburn et al., 1988).
The first evidence supporting the hypothesis that the airway epithelium releases an
inhibitory factor capable of modulating the reactivity of adjacent smooth muscles came in 1986
with the development of the coaxial bioassay preparation. This preparation consisted of an
endothelium-denuded rabbit aortic strip (recipient tissue) positioned within the lumen of an
epithelium-intact or -denuded guinea-pig trachea (donor tissue) (Figure 7A). By attaching the
endothelium-denuded rabbit aortic strip to an isometric force transducer, contractile and relaxant
responses of this tissue could be measured. Following the contraction of the aortic strip with
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phenylephrine, an "1-adrenoceptor agonist, ACh was added to the preparation which
subsequently relaxed the aortic strip. When the epithelium was removed from the guinea-pig
trachea, and the same experiment repeated, the aortic strip failed to relax (Ilhan and Sahin, 1986)
(Figure 7B). Coaxial bioassay experiments from other laboratories reported similar results when
guinea-pig tracheal smooth muscle or rat anococcygeus muscle were used as the recipient tissue
(Güc et al., 1988a; Güc et al., 1988b), or when human bronchus was used as a donor to relax
phenylephrine-contracted rat aortic strips (Fernandes et al., 1990). In all of these coaxial
bioassay experiments, as in the original, removal of the epithelium from the donor tissue
abolished the relaxation response of the recipient tissue, supporting the notion that the relaxation
of the recipient tissue was dependent upon an epithelium-derived relaxing factor, EpDRF.
Further pharmacological characterization of EpDRF with the coaxial bioassay preparation
demonstrated that this factor was not a product of nitric oxide synthase, cyclooxygenase,
lipoxygenase, or the cytochrome P450 enzyme systems. This same study showed that EpDRF
was not related to free radical production, soluble guanylate cyclase, $-adrenoceptors, or
platelet-activating factor (Fernandes and Goldie, 1990).
Until the late 1980s, EpDRF was studied using rings or strips of airway tissue, which had
limited usefulness. In 1988 the guinea-pig isolated, perfused trachea apparatus was developed,
allowing for much more elegant EpDRF studies (Munakata et al., 1988). This preparation
allowed pharmacological agents to be added separately to either the extraluminal (serosal) or
intraluminal (mucosal) surfaces of the trachea. In this preparation, contractile agonists added to
the extraluminal surface were more potent since they had direct access to the smooth muscle.
Agents added to the intraluminal surface must first diffuse through the epithelium before
interacting with the smooth muscle. Early experiments with this preparation (Munakata et al.,
1988) demonstrated that increasing the tonicity of the solution perfusing the intraluminal surface
of the trachea was a major stimulus for the release of EpDRF.
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Figure 7. Coaxial bioassay preparation. (A) A diagram of the coaxial bioassay preparation
whose use was first reported by Ilhan and Sahin in 1986. (B) A schematic illustration of the
experimental results obtained from this preparation. The addition of ACh to an endotheliumdenuded, phenylephrine (PE)-contracted, rabbit aortic strip within an epithelium-intact (+Epi),
guinea-pig trachea relaxed the aortic strip. When the same experiment was repeated using an
epithelium-denuded (-Epi), guinea-pig trachea, the aortic strip failed to relax; thus, the ability of
the epithelium to produce a transferrable EpDRF was concluded (illustration produced by and
courtesy of Jeffrey S. Fedan, Ph.D.).
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When hypertonic solutions of NaCl, KCl, urea, or mannitol were added to the intraluminal
surface of a carbachol-contracted trachea, the smooth muscle relaxed. When the experiment was
repeated in epithelium-denuded trachea, smooth muscle relaxation was significantly attenuated,
demonstrating that the relaxation response evoked by hypertonic solution was epitheliumdependent (Munakata et al., 1988). A separate study later demonstrated that increasing the
tonicity of the extraluminal surface of the trachea also stimulated EpDRF-induced smooth
muscle relaxation (Fedan et al., 1999). It has also been shown that stimulating the release of
EpDRF with hypertonic solution decreased smooth muscle reactivity to methacholine and
transmural nerve stimulation (Fedan et al., 1999). Although it has been shown that elevated
extraluminal and intraluminal tonicity elicit epithelium-dependent smooth muscle relaxation via
EpDRF, EpDRF’s mechanism of action as well as its identity remains largely obscure.
It has been demonstrated clearly that EpDRF-induced smooth muscle relaxation, evoked
by hypertonic solution, is unaffected by nitric oxide synthase inhibitors, indomethacin,
methylene blue, propranolol, and tetrodotoxin (Munakata et al., 1988, 1990; Fedan et al., 1999).
Interestingly, gossypol, a dual cyclooxygenase-lipoxygenase inhibitor and oxygen radical
scavenger, and hemoglobin attenuate relaxation responses to elevated intraluminal tonicity
(Teeter et al., 1988; Munakata et al., 1990; Fedan and Johnston, unpublished). Because
hemoglobin, and not nitric oxide synthase inhibitors, attenuates EpDRF-induced smooth muscle
relaxation, this suggests that carbon monoxide may play a role in the relaxation response to
elevated tonicity since carbon monoxide is capable of binding to hemoglobin (West, 1995).
Previous work has suggested that the synthesis, release, and/or effects of EpDRF may be
functionally linked to the electrical activity of epithelial cells (Raeburn and Fedan, 1989). Fedan
et al. (1999) reported that amiloride-sensitive Na+ channels and 4-4'-diisothiocyanatostilbene-22' disulfonic acid (DIDS)-sensitive Cl! channels seem to be involved in EpDRF-induced smooth
muscle relaxation. Both amiloride and DIDS attenuate EpDRF-induced smooth muscle
relaxation responses elicited by elevated intraluminal tonicity. Fedan et al. (1999) also reported
that the Na+-K+-2Cl! cotransporter and the Na+-K+-ATPase play virtually no role in EpDRF17

induced smooth muscle relaxation. A separate study reported that epithelial Ca2+-activated K+
channels may be involved in the synthesis and/or release of EpDRF (Tamaoki et al., 1997).
Dortch-Carnes et al. (1999) recently modified the isolated, perfused trachea apparatus to measure
transepithelial potential difference simultaneously with smooth muscle contraction and
relaxation. This modified preparation has provided more evidence that the synthesis, release,
and/or effects of EpDRF are functionally linked to epithelial electrical activity. Dortch-Carnes et
al. (1999) have reported that depolarization of the transepithelial potential difference precedes
EpDRF-induced smooth muscle relaxation elicited by elevating intraluminal tonicity with either
ionic or non-ionic osmolytes (Dortch-Carnes et al., 1999). A summary of EpDRF’s actions are
illustrated in Figure 8.

Cell-Volume Regulation in Response to Hypertonic Challenge
When exposed to anisotonic solutions, cells activate volume regulatory mechanisms to
either maintain or return to their normal volume
(Parker, 1993; McManus et al., 1995; Haüssinger, 1996). When the tonicity of the mucosal and
serosal surfaces of the airway epithelium are elevated, this is a major stimulus for the synthesis,
release, and/or effects of EpDRF (Munakata et al., 1988; Fedan et al., 1999), it is therefore
essential to understand the principles of cell-volume regulation as they pertain to hypertonic
challenge. A cell loses water when exposed to a hypertonic environment. In order to regain its
normal volume, the cell activates regulatory volume increase (RVI) mechanisms. Increases or
decreases in cell volume can only be achieved by the gain or loss, respectively, of osmotically
active solutes. Osmotically active solutes include inorganic ions such as Na+, K+, and Cl! and
small, organic osmolytes. These small, organic osmolytes are divided into three major classes:
(1) amino acids and their derivatives (i.e., alanine, proline, and taurine), (2) methylamines (i.e.,
betaine and glycerylphosphorylcholine), and (3) polyols (i.e., sorbitol and myo-inositol). These
molecules are sometimes referred to as non-perturbing osmolytes since the cell can accumulate
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high concentrations of these substances without deleterious effects on cell structure and function
(McManus et al., 1995; Lang et al., 1998). RVI mechanisms occur in two steps. First, within
seconds after exposure to a hypertonic environment, a cell increases its net gain of Na+ and Cl!
to maintain its volume through activation of the Na+-K+-2Cl! cotransporter and the Na+-H+
exchanger, both of which are present on airway epithelial cells. Because the intracellular pH is
altered by the activity of the Na+-H+ exchanger, there is subsequent activation of the Cl!-HCO3!
exchanger (Clarke and Boucher, 1993; McManus et al., 1995; Lang et al., 1998).
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Figure 8. Actions of the airway epithelium-derived relaxing factor (EpDRF). EpDRF is known
to be released when the tonicity of either the apical or basolateral surfaces of the airway
epithelium are elevated, which in this illustration is denoted by NaCl. Once released, EpDRF
can relax the airway smooth muscle. It is still questionable whether or not EpDRF can relax
vascular smooth muscle or if it is capable of attenuating the effects of ACh released from
postganglionic parasympathetic nerve terminals. Epi, airway epithelium; VSM, vascular smooth
muscle; ASM, airway smooth muscle; ACh, acetylcholine (illustration produced by and courtesy
of Jeffrey S. Fedan, Ph.D.).
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The second step involves the accumulation of small organic osmolytes by activating the
transcription of genes encoding osmolyte synthetic enzymes and transporters (Figure 9). These
osmolytes are accumulated along with Na+ by means of Na+-coupled osmolyte transporters, and
this process can last for hours or days (McManus et al., 1995; Lang et al., 1998). In addition
during RVI, cells breakdown cytoplasmic proteins while the anabolic pathways leading to the
synthesis of organic osmolytes are increased (Haüssinger, 1996).

Exercise-Induced Asthma
In general, asthma can be defined as a chronic, inflammatory airway disease
characterized by reversible airway obstruction. Asthma affects over 5% of the inhabitants of the
world’s industrialized countries (Shelhamer et al., 1995; Barnes et al., 1998). In the United
States as many as twelve million persons may be afflicted with asthma (Shelhamer et al., 1995).
The most common pathophysiological features of asthma include: (1) sloughing and
desquamation of the respiratory epithelium, (2) thickening of the respiratory epithelial basement
membrane, (3) goblet cell hyperplasia, (4) submucosal gland enlargement, (5) airway smooth
muscle hypertrophy and hyperplasia, (6) dilation of the bronchial vasculature, (7) airway edema,
(8) recruitment of inflammatory cells into the airways (Jeffrey, 1998),
and (9) nonspecific airway hyperreactivity to nonsensitizing physical or chemical stimuli
(Cockcroft and O'Byrne, 1993).
Approximately 70-80% of asthmatics experience exercise-induced asthma (EIA) which is
a general term used to describe a transient increase in airway resistance following strenuous
exercise. A decrease of 10% or more in the volume of air forcibly expired in one second (FEV1)
following exercise is used to diagnose EIA (Anderson, 1985; Anderson and Daviskas, 1999).

21

Figure 9. Mechanisms of regulatory volume increase (RVI). The RVI mechanisms occur in two
steps. First, immediately after cells shrink due to exposure to a hypertonic environment, cells
accumulate inorganic ions, namely Na+ and Cl! through the activation of the Na+-K+-2Cl!
cotransporter, the Na+-H+ exchanger, and subsequently the Cl!-HCO3! exchanger. The second
step occurs over many hours or days and involves the accumulation of organic osmolytes via the
induction of genes encoding for osmolyte synthetic enzymes and ion-coupled transporters.
5'•AAA3' represents elevations in mRNA levels to convey an up-regulation of the transcription
of genes encoding osmolyte synthetic enzymes and ion-coupled transporters. Figure adapted
with permission from McManus ML, Churchwell KB and Strange K (1995) Regulation of cell
volume in health and disease, N Engl J Med 333:1260-1266.
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EIA is the most extreme five to ten minutes upon the cessation of exercise; however, a refractory
period exists for up to three hours after the initial attack has ended
(Anderson, 1985; McFadden, 1995). In contrast to asthmatics who may experience
bronchoconstriction following exercise, normal individuals may actually experience
bronchodilation during exercise (Kagawa and Kerr, 1970). Many hypotheses have tried to
explain the phenomenon of EIA (Freed, 1995); however, two hypotheses in particular have
gained the most attention: (1) the thermal hypothesis of EIA and (2) the osmotic theory of EIA.
Most of the experimental evidence seems to support the osmotic theory of EIA
(McFadden, 1995; Anderson and Daviskas, 1999) which is described in the following
paragraphs.
Because of temperature and water vapor concentration gradients, heat and water are
added to the inspired air as it passes over the respiratory mucosa of the conducting airways, a
process referred to as conditioning. Under normal physiological conditions, most of the inspired
air is conditioned by the time it reaches the oropharynx. During strenuous exercise, an
individual’s ventilation rate increases dramatically; therefore, the respiratory tract has to
condition a greater volume of air over a much shorter period of time. As a consequence, more
airways are actively recruited to condition the inspired air, and in the process, the respiratory
mucosa loses more heat and water than normal to the inspired air. The ASL is the major source
of water used to condition the inspired air during exercise. The water lost from the ASL during
exercise is not readily replaced, and as a result, the osmolarity of the ASL increases
(Anderson and Daviskas, 1999).
The osmotic theory of EIA suggests that the increased ASL osmolarity results in the
release of bronchoactive mediators from the epithelium, bronchial mucosal mast cells, and
sensory nerves which lead to EIA. Spasmogenic substances released from these cells include
prostaglandin D2, leukotrienes, histamine, and substance P, all of which can readily diffuse to the
smooth muscle and initiate bronchoconstriction. Increasing the osmolarity of the ASL also leads
to the release of bronchorelaxant substances from the airway epithelium, including NO,
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prostaglandin E2, and EpDRF
(Munakata et al., 1988; Anderson and Daviskas, 1999; Fedan et al., 1999). The effects of airway
drying on the airway epithelium and surrounding cells of the airway wall are illustrated in Figure
10.
The osmotic theory of EIA explains why some asthmatics could experience
bronchoconstriction following exercise whereas normal individuals do not. In asthmatics, the
airway epithelium is sloughed and desquamated (Laitinen et al., 1985), and as a consequence,
more airways would have to be recruited to condition the inspired air. This could lead to an
increase in the ASL osmolarity throughout the respiratory tract, resulting in the release of
bronchospastic mediators from various sources to initiate EIA (Anderson and Daviskas, 1999).
In normal individuals, the intact epithelium may produce enough bronchorelaxant factors (NO,
PGE2, and EpDRF) to offset the effects of these bronchospastic mediators; therefore EIA is
prevented.

24

Figure 10. The effects of airway drying on the airway epithelium and airway wall. (A) The net
direction of ion and water movement across the airway epithelium under normal, physiological
conditions is indicated by the arrows. (B) Evaporative water loss (airway drying) as a result of
hyperpnea reduces the depth of the periciliary fluid or ASL and increases its concentration of
inorganic ions; thus, its osmolarity is elevated. This results in the release of bronchoactive
mediators from the epithelium and the vascular endothelium of bronchial vessels in the airway
wall. These mediators are capable of diffusing to the airway smooth muscle and modulating its
tone. In addition, water movement from the submucosal tissues increases during this time in
order to replenish the water lost from the periciliary fluid during airway drying. PGs,
prostaglandins; NO, nitric oxide. Reprinted from Anderson SD and Daviskas E (1999) Airway
drying and exercise-induced asthma, in Exercise-Induced Asthma (McFadden ER ed) pp 77-113
by courtesy of Marcel Dekker Inc.
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Lipopolysaccharide, Sepsis, and Acute Respiratory Distress Syndrome
Lipopolysaccharide (LPS) is an amphiphilic macromolecule which is the major
component of the outer membrane of gram-negative bacteria (Figure 11A). LPS consists of two
major structural components: a polysaccharide portion and a lipid A portion. The lipid A
component is covalently bound on one side to the outer membrane of the bacterium whereas the
polysaccharide portion is bound to the other end of the lipid A component and extends into the
extracellular space. As Figure 11B illustrates, the polysaccharide portion can be further
subdivided into a core region and an O-specific chain. The lipid A portion is highly conserved
among gram-negative bacteria and is the toxic component of the LPS macromolecule. As gramnegative bacteria die or begin to replicate, LPS is released and capable of initiating its
pathological effects (Lüderitz et al., 1982; Rietschel et al., 1994, 1996; Raetz, 1996).
LPS, in itself, is not toxic, but it is the immunologic and inflammatory events that it
initiates which are detrimental. Various serum proteins are capable of modulating the effects of
LPS, but the most important is the lipopolysaccharide-binding protein (LBP). By binding to the
LBP, the LPS macromolecule is delivered to a membrane-bound receptor, CD14, found on
macrophages and monocytes, and once bound, LPS-induced signal transduction can commence
(Rietschel et al., 1996). LPS stimulates a wide variety of cellular processes, some of which are
summarized in Figure 12. An overwhelming gram-negative bacterial infection can result in
sepsis and/or acute respiratory distress syndrome (ARDS).
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Figure 11. Localization of lipopolysaccharide (LPS) and its chemical components. (A) LPS is
the major component of the outer membrane of gram-negative bacteria. GluNAc, N-acetyl-Dglucosamine; KDO, 3-deoxy-D-manno-octulosonic acid; MDO, membrane-derived
oligosaccharides. Reprinted with permission from Raetz CRH (1996) Bacterial
lipopolysaccharides: A remarkable family of bioactive macroamphiphiles, in Escherichia coli
and Salmonella: Cellular and molecular biology (Neidhardt FC ed) pp 1035-1063, ASM Press,
Washington, D.C. (B) The LPS macromolecule is divided into two major regions: the lipid A
portion and the polysaccharide portion. The polysaccharide region can be further subdivided.
Reprinted with permission from, Academic Press Ltd, London UK.
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Figure 12. Toxic effects of lipopolysaccharide (LPS). As gram-negative bacteria begin to
replicate or die, LPS is released and capable of exerting its pathological effects. If a gramnegative bacterial infection is severe enough, it can result in sepsis. TNF", tumor necrosis factor
"; IL-1, interleukin-1; IL-6, interleukin-6; PAF, platelet-activating factor; IL-2, interleukin-2.
Reprinted with permission from Bone RC (1991) The pathogenesis of sepsis, Ann Int Med
115(6):457-469.
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As defined by the American College of Chest Physicians/Society of Critical Care
Medicine, sepsis is the systemic response to infection (Bone, 1996), and as many as 500,000 new
cases are reported annually in the United States (Sessler et al., 1996). Sepsis is a serious medical
condition with a 40% mortality rate (Marsh and Wewers, 1996). A few of the clinical
manifestations of sepsis include fever, hypothermia, tachycardia, tachypnea, oliguria, acidosis,
and hypotension (Rietschel et al., 1996). Fifty percent of those individuals diagnosed with sepsis
develop ARDS within the first twenty-four hours after the onset of sepsis. Acute lung injury is
recognized clinically as ARDS (Sessler et al., 1996). The clinical manifestations of ARDS
include arterial hypoxemia, dyspnea, decreased lung compliance, pulmonary edema, and
atelectasis (McFeely and Hudson, 1994; Sessler et al., 1996).
This dissertation describes an investigation into two separate, but related questions
pertaining to the role and mechanism(s) of action of EpDRF. In the first, the effects of epithelial
ion transport inhibitors on the epithelial bioelectric response to elevated mucosal tonicity were
examined in order to elucidate which ion channels and/or transporters are involved in the
epithelial depolarization which precedes EpDRF-induced smooth muscle relaxation. In the
second study, the effects of LPS-treatment on EpDRF-induced smooth muscle relaxation and
related bioelectric events were examined, since LPS has been implicated in a number of
pulmonary diseases.
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The Relationship Between Epithelial Bioelectric
Responses and Epithelium-Derived Relaxing FactorInduced Airway Smooth Muscle Relaxation in
Response to Hypertonic Solution
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Objectives
When cells are exposed to a hypertonic environment, they activate RVI mechanisms
which alter ion transport through perturbations in ion channel and/or transporter activity
(McManus et al., 1995; Lang et al., 1998). In addition, when the extraluminal (serosal) and
intraluminal (mucosal) surfaces of guinea-pig tracheal epithelium are challenged with
hypertonicity, EpDRF is released (Munakata et al., 1988; Fedan et al., 1999), an event which
seems to be functionally linked to epithelial ion transport (Dortch-Carnes et al., 1999; Fedan et
al., 1999). With a consideration of these statements, the purpose of this study was to characterize
further the epithelial bioelectric events associated with the synthesis, release, and/or effects of
EpDRF in guinea-pig isolated trachea.
The hypothesis underlying this study was that hypertonicity-induced alterations in
epithelial ion transport are functionally linked to the synthesis, release, and/or effects of EpDRF.
The hypothesis was tested by measuring transepithelial short-circuit current (Isc) responses to
pharmacological agents added to either surface of guinea-pig isolated trachea mounted in Ussing
chambers. Dortch-Carnes et al. (1999) have shown that EpDRF-induced smooth muscle
relaxation is preceded by a depolarization of the transepithelial potential difference while Fedan
et al. (1999) have shown that EpDRF-induced smooth muscle relaxation is significantly
attenuated by amiloride (Na+ channel blocker) and DIDS (Cl! channel blocker). The
experiments in this study will try to determine which epithelial ion channels and/or transporters
are involved in the transepithelial depolarization preceding EpDRF-induced airway smooth
muscle relaxation. This will be accomplished by examining the effect of various ion channel and
transporter inhibitors on Isc responses to hypertonic modified Krebs Henseleit (MKH) solution.
In this study, the MKH solution was made hypertonic by adding either 120 mOsm NaCl or Dmannitol to the MKH solution.
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Materials and Methods
Animals
Specific, pathogen-free, male Dunkin-Hartley guinea pigs (Harlan Sprague Dawley, Inc.;
Indianapolis, IN; 370-714 g) were used during the course of this study. The guinea pigs were
housed in separate, actively ventilated, micro-isolator cages (Lab Products, Inc.; Seaford, DE)
within a single room. The room within which these animals were housed were part of an 8800
ft2 modified barrier, animal care facility. Within this facility, the animals were acclimated to
their new environment prior to experimentation, given food and water ad libitum, and breathed
fresh air. All of the animals in the animal care facility, as well as the facility itself, were under
the supervision of a full-time veterinarian.
Throughout this study, the guinea pigs were sacrificed according to a standard protocol.
The animals were first anesthetized intraperitoneally (i.p.) with sodium pentobarbital (Veterinary
Laboratories, Inc.; Lenexa, KS; 65 mg/kg), and once it was determined that the animals were
unresponsive to any stimuli, they were exsanguinated by severing the abdominal aorta and
cutting the heart.
All of the experimental protocols in this study were approved by the Institutional Animal
Care and Use Committee (IACUC) while the facilities where the experimental protocols were
conducted were fully accredited by the Association for the Assessment and Accreditation of
Laboratory Animal Care (AAALAC) International. These facilities have been accredited by
AAALAC International since February 18, 1987.

Ussing System
A classical Ussing system [World Precision Instruments (WPI); Sarasota, FL] was
utilized to directly measure Isc in freshly isolated, guinea-pig tracheal segments. Isc can be
defined as the current required to offset the spontaneous transepithelial potential difference
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generated by the tissue. Under Isc conditions there is no net ion transport; therefore, Isc is a
measurement of total active ion transport (Soybel, 1994).
The Ussing system consisted of two separate, water-jacketed, glass circulation reservoirs
whose temperature was maintained at 37oC. The reservoirs were filled with recirculating, MKH
solution, a physiological salt solution, which was maintained at 37oC and continuously gassed
with 95% O2-5% CO2. The reservoirs were connected to opposing hemi-chambers, between
which a guinea-pig tracheal segment was mounted. Because of the manner in which the tissue
was mounted, pharmacological agents could be added selectively to either the mucosal or serosal
surfaces of the trachea.
In order to prepare a guinea-pig tracheal segment for mounting, the animal was sacrificed
as previously described. The trachea was exposed in vivo, the entire trachea excised, placed in
MKH solution gassed with 95% O2-5% CO2, and cleaned of extraneous tissue. Once cleaned,
the trachea was slit along its longitudinal axis by cutting through the airway smooth muscle. The
trachea was then opened as a flat sheet and cut horizontally so that the proximal end of the
trachea was mounted in the Ussing chamber. After mounting, only a 0.125 cm2 surface area of
the trachea was exposed to the gassed, MKH solution from the glass circulation reservoirs.
The fluid which bathed the mucosal and serosal surfaces of the trachea was in contact
with silver/silver chloride electrode cartridges (WPI; Sarasota, FL) which were filled with 0.9 %
sodium chloride irrigation, USP (saline; Baxter Healthcare Corporation; Deerfield, IL) in 4 %
melted bacteriological agar. A two-channel DVC-1000 voltage/current clamp (WPI; Sarasota,
FL) was connected to the Ussing chamber via four silver/silver chloride electrodes. Two
electrodes, placed distal to the tissue, were connected to the current-passing circuit while two
electrodes, placed proximal to the tissue, monitored transepithelial potential difference. Isc was
measured continuously, and the data recorded on a conventional strip chart recorder (Gould
Instrument Systems; Valley View, OH). In addition, the Isc was normalized to surface area. To
accomplish this, the Isc was multiplied by the inverse of the surface area of the trachea exposed to
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the fluid bathing the mucosal and serosal surfaces. In this instance, the surface area was
calculated from the formula describing the surface area of a circle:
surface area of a circle = Br2
where r is the radius (0.2 cm). The following sample calculation demonstrates how the Isc was
eventually expressed in µA/cm2:
Isc×(1/Br2)
then, by substitution of arbitrary numerical values
5.0 µA×1/[B(0.2 cm)2] = 39.8 µA/cm2
The tissue was equilibrated for 3 hr prior to any experimental manipulations, with the MKH
solution bathing the mucosal and serosal surfaces of the trachea being changed every 15 min.

Administration of Agents to the Ussing System
The Ussing system was used in this study to determine the effect of amiloride (Na+
channel blocker), 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB; Cl! channel blocker),
iberiotoxin (Ca2+-activated K+ channel blocker), bumetanide (Na+-K+-2Cl! cotransporter
inhibitor), and ouabain (Na+-K+-ATPase inhibitor) on tracheal Isc responses to hypertonic
solution. During this portion of the study, the effect of a single concentration of hypertonic
solution on Isc was examined, and in this instance, the MKH solution was made hypertonic by
adding either120 mOsm of NaCl or D-mannitol to the MKH solution.
Following the 3 hr equilibration period, hypertonic NaCl or D-mannitol solution was
added to the mucosal surface of the trachea in the presence of serosally-added methacholine
chloride (MCh; 3×10!7 M) in order to mimic conditions in previous EpDRF studies
(Dortch-Carnes et al., 1999; Fedan et al., 1999). Once the electrophysiological response to
hypertonic solution had equilibrated, the preparation was then washed at 15 min intervals for 90
min with fresh MKH solution.
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After the completion of the 90 min wash period, a respective ion channel and/or
transporter inhibitor was added to either the mucosal or serosal surface of the trachea, depending
upon the epithelial surface where its molecular target is believed to exist (Figure 6). Once the
electrophysiological response of the inhibitor, if any, had equilibrated, hypertonic NaCl or Dmannitol solution was added again to the mucosal surface of the trachea in the presence of
serosally-added MCh (3×10!7 M). There were a few exceptions to this standard protocol.
Iberiotoxin was added to both the mucosal and serosal surfaces of the trachea for 30 min while
ouabain was added prior to the addition of MCh to mimic conditions in a previous EpDRF study,
which was done to prevent Na+ loading of the tracheal smooth muscle (Fedan et al., 1999).

Solutions and Reagents
The MKH solution contained (mM): NaCl (113.0), KCl (4.8), CaCl2 (2.5), KH2PO4
(1.2), MgSO4 (1.2), NaHCO3 (25.0), and glucose (5.7). The MKH solution was continuously
gassed with 95% O2-5% CO2 and maintained at 37oC and a pH of 7.4. In addition, the
osmolarity of the MKH solution was 281.2±0.6 mOsm (n = 5; Osmette A Automatic
Osmometer, Precision Systems, Inc.; Sudbury, MA).
All chemical reagents used during the course of this study were purchased from Sigma
Chemical Co. (St. Louis, MO) and dissolved in distilled water unless otherwise noted.
Amiloride and ouabain were dissolved in warm, distilled water while bumetanide and NPPB
were dissolved in dimethyl sulfoxide (DMSO).

Analysis of Results
When statistically comparing the UIsc in response to hypertonic MKH solution in the
presence and absence of ion channel or transporter inhibitors, the paired Student’s t test or MannWhitney rank sum test was used, as appropriate.
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All of the results were expressed as the mean ± S.E.M. (standard error of the mean)
where n is the number of separate experiments. In every experiment, p < 0.05 was considered
significant.

Results
Effect of ion transport inhibitors on the basal Isc of isolated trachea
The basal Isc of guinea-pig isolated, trachea mounted in Ussing chambers was 47.8±1.6
µA/cm2 (n = 64). Treatment of the tissue with mucosally-applied amiloride (3×10!5 M),
mucosally-applied NPPB (10!4 M), or serosally-applied bumetanide (10!5 M) decreased the
basal Isc by 35.6±1.4% (n = 12), 83.3±4.9% (n = 8), and 8.9±1.6% (n = 12), respectively.
Mucosally- and serosally-applied iberiotoxin (10!7 M) had no apparent effect upon the basal Isc.
In order to mimic previous studies of EpDRF in the isolated, perfused trachea apparatus (Fedan
et al., 1999), the effect of serosally-applied ouabain (10!5 M) on Isc was measured in the presence
of serosally-applied MCh (3×10!7 M). In this instance, ouabain decreased the Isc by 94.3±3.3%
(n = 8).

Effect of ion transport inhibitors on the bioelectric responses of
isolated trachea to hypertonic NaCl and D-mannitol solution
In order to characterize further the ion channels and/or transporters involved in EpDRFinduced smooth muscle relaxation (Dortch-Carnes et al., 1999; Fedan et al., 1999), this study
examined the effect of ion channel and transporter inhibitors on the Isc responses of isolated
trachea to MKH solution made hypertonic with either added NaCl (120 mOsm) or D-mannitol
(120 mOsm), both of which have been shown to elicit EpDRF-induced smooth muscle relaxation
(Munakata et al., 1988; Fedan et al., 1999). Again, in order to mimic previous studies of EpDRF
(Dortch-Carnes et al.,
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1999; Fedan et al., 1999), MCh (3×10!7 M) was added serosally prior to the mucosal application
of hypertonic NaCl or D-mannitol solution. MCh, itself, increased the Isc which was
significantly attenuated by bumetanide and NPPB (data not shown).
In the presence of serosally-added MCh (3×10!7 M), the bioelectric responses to
hypertonic NaCl and D-mannitol solution were different (Figure 13). Mucosally-applied
hypertonic NaCl solution produced a triphasic response which consisted of a rapid decrease, an
increase, and finally, a very slow, sustained decrease in Isc. The triphasic Isc responses were
difficult to quantify since the first two phases, the rapid decrease and then increase, were variable
from tissue to tissue; however, the very slow, sustained decrease in Isc was characteristic of all
tissue responses to hypertonic NaCl solution. As a consequence, the very slow, sustained
decrease in Isc was the only phase which was quantified. The response to hypertonic D-mannitol
solution was much less complex, consisting of only a very slow, sustained decrease in Isc.
Pretreatment with either serosally-applied amiloride (3×10!5 M) or bumetanide (10!5 M)
significantly inhibited the UIsc induced by NaCl and D-mannitol (Figures 14 and 15) while
mucosally- and serosally-applied iberiotoxin (10!7 M) had no apparent effect on the Isc responses
to either NaCl or D-mannitol (Figure 16). In the presence of mucosally-applied NPPB (10!4 M),
the Isc increased rather than decreased following the addition of NaCl while the UIsc induced by
D-mannitol was almost completely abolished (Figure 17). Serosally-added ouabain (10!5 M)
caused a progressive reduction in Isc toward zero. This prevented assessment of the effect of
ouabain on responses to NaCl and D-mannitol; however, in the presence of ouabain, the Isc
increased rather than decreased following the application of NaCl and D-mannitol (Figure 18).
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Figure 13. Representative tracing showing the effect of mucosally-applied MKH solution made
hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol (120 mOsm) on Isc in the
presence of serosally-applied MCh (3×10!7 M) in isolated trachea. MCh increased the Isc. NaCl
elicited a triphasic response which consisted of (1) a rapid decrease, (2) an increase, and finally,
(3) a very slow, sustained decrease in Isc. D-mannitol elicited a very slow, sustained decrease in
Isc. As explained in the text, it was the very, slow sustained decrease in Isc which was quantified.
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Figure 14. Effect of mucosally-applied amiloride (3×10!5 M) on the Isc responses of mucosallyapplied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.
Amiloride significantly inhibited the UIsc induced by both NaCl and D-mannitol. n = 6 for NaCl
and D-mannitol. *p < 0.05 compared to !Amiloride as determined by a paired Student’s t test.
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Figure 15. Effect of serosally-applied bumetanide (10!5 M) on the Isc responses of mucosallyapplied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.
Bumetanide significantly inhibited the UIsc induced by both NaCl and D-mannitol. n = 6 for
NaCl and D-mannitol. *p < 0.05 compared to !Bumetanide as determined by a paired Student’s
t test.
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Figure 16. Lack of effect of mucosally- and serosally-applied iberiotoxin (10!7 M) on the Isc
responses of mucosally-applied MKH solution made hypertonic with added (A) NaCl (120
mOsm) or (B) D-mannitol (120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in
isolated trachea. n = 4 for NaCl and D-mannitol.
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Figure 17. Effect of mucosally-applied NPPB (10!4 M) on the Isc responses of mucosallyapplied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea. In the
presence of NPPB, the Isc increased rather than decreased following the addition of NaCl while
the UIsc induced by D-mannitol was almost completely abolished. n = 4 for NaCl and Dmannitol. *p < 0.05 compared to !NPPB as determined by a paired Student’s t test.
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Figure 18. Effect of serosally-applied ouabain (10!5 M) on the Isc responses of mucosallyapplied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol
(120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea. Ouabain
(10!5 M) caused a progressive reduction in Isc toward zero. This prevented assessment of the
effect of ouabain on responses to NaCl and D-mannitol; however, in the presence of ouabain, the
Isc increased rather than decreased following the application of NaCl and D-mannitol. n = 4 for
NaCl and D-mannitol. *p < 0.05 compared to !Ouabain as determined by a paired Student’s t
test.
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In order to make certain that the responses seen in the presence of the inhibitors were not
due to the effects of the vehicle, DMSO, the effect of DMSO on the responses was tested.
DMSO had no effect upon the responses to hypertonic NaCl or D-mannitol solution (Figure 19).
Finally, to ensure that tissue desensitization did not contribute to the apparent effect of the
inhibitors, the effect of hypertonic NaCl and D-mannitol solution on Isc responses was measured
twice in the same preparation (Figure 20). The second response was measured 90 min after the
first, with washes every 15 min. There was no difference between the first and second response
to D-mannitol, but there was a significant decrease in the second NaCl response when compared
to the first.
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Figure 19. Lack of effect of mucosally- and serosally-applied DMSO on the Isc responses of
mucosally-applied MKH solution made hypertonic with added (A) NaCl (120 mOsm) or (B) Dmannitol (120 mOsm) in the presence of serosally-applied MCh (3×10!7 M) in isolated trachea.
The final concentration of DMSO bathing the mucosal surface of the trachea was 0.08% while
the final concentration bathing the serosal surface of the trachea was 0.01%. n = 4 for NaCl and
D-mannitol.
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Figure 20. Comparison of the first and second Isc responses to mucosally-applied MKH solution
made hypertonic with added (A) NaCl (120 mOsm) or (B) D-mannitol (120 mOsm) in the
presence of serosally-applied MCh (3×10!7 M) in isolated trachea. The second UIsc induced by
NaCl was slightly, but significantly less than the first while there was no difference between the
first and second UIsc induced by D-mannitol. n = 4 for NaCl and D-mannitol. *p < 0.05
compared to the first response as determined by a paired Student’s t test.
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Discussion
The results of this study suggest that apical Na+ channels and basolateral Na+-K+-2Cl!
cotransporters are intimately involved in the airway epithelial bioelectric response to elevated
mucosal tonicity while the role of apical Cl! channels and basolateral Na+-K+-ATPases is
unclear. Since apical Na+ channels are involved in both the epithelial bioelectric response to
elevated mucosal tonicity and hypertonicity-induced smooth muscle relaxation via EpDRF, this
further strengthens the hypothesis that the synthesis, release, and/or effects of EpDRF are
functionally linked to the electrical activity of the epithelium (Raeburn and Fedan, 1989; DortchCarnes et al., 1999; Fedan et al., 1999).
Although the major objective of this study was to elucidate which epithelial ion channels
and/or transporters were involved in the depolarization of the transepithelial potential difference
(Vms) preceding EpDRF-induced smooth muscle relaxation, this study has made other
observations regarding the basic electrophysiological properties of guinea-pig tracheal
epithelium. The basal Isc value obtained in this study was not consistent with two previous
studies measuring Isc in guinea-pig tracheal epithelium (Croxton, 1993; Robison and Kim, 1994).
The reasons for these discrepancies are not clear; however, both of these studies used animals in
a lower weight range which may be important if epithelial ion transport is size- and/or agedependent. More importantly, the difference may lie in the arrangement of the tissue. Croxton
(1993) measured Isc in intact trachea while Robison and Kim (1994) measured Isc in cultured,
tracheobronchial epithelial cells. This is most significant when comparing our results with those
from cultured cells since submucosal tissues have been shown to modulate the bioelectric
properties of the airway epithelium (Freed and Croxton, 1993). The lack of an airway wall and
its modulatory effects in cultured cells may explain these differences. Our basal Isc value
(47.8±1.6 µA/cm2), however, was consistent with a separate study (37.3±2.9 µA/cm2) which also
measured Isc in guinea-pig tracheal segments mounted in Ussing chambers
(Stutts and Bromberg, 1987).
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The effects of several ion transport inhibitors on the basal Isc produced results which
contradicted the current, presumed model of ion transport in guinea-pig tracheal epithelium. The
current model proposes that under resting Isc conditions Na+ absorption is the major ion transport
process which accounts for the majority of the Isc (Boucher et al., 1982). In this study, amiloride
decreased the basal Isc by 35.6±1.4% which is consistent with a Na+ absorptive epithelium;
however, other studies have shown the effect of amiloride on baseline Isc to be much greater.
Croxton (1993) reported that amiloride (3×10!5 M) decreased the baseline Isc by approximately
50% while Robison and Kim (1994) reported that amiloride (10!5 M) decreased the baseline Isc
by approximately 75%. Again, these discrepancies may be explained by the same reasons given
for the differences seen in the basal Isc among the different preparations.
Our results became more contradictory when the effect of NPPB, a Cl! channel blocker,
on baseline Isc was examined. NPPB abolished 83.3±4.9% of the basal Isc. Despite the fact that
the current model of ion transport in guinea-pig tracheal epithelium proposes that there is no net
Cl! secretion (Boucher et al., 1982), our results with NPPB suggest that Cl! secretion may be the
predominant ion transport process of this epithelium. Robison and Kim (1994) used another Cl!
channel blocker, N-phenylanthranilic acid, which decreased the basal Isc of cultured,
tracheobronchial epithelial cells by approximately 20 %. On the surface, the effect of NPPB
suggests that the majority of the Isc is due to Cl! secretion; however, NPPB is a nonselective Cl!
channel blocker. In fact, NPPB has been shown to inhibit the Ca2+ release-activated Ca2+
channel as well as the activity of the Na+-K+-ATPase which may account for its large inhibition
of baseline Isc (Ito et al., 2000; Li et al., 2000).
With respect to the effect of hypertonic solution on Isc responses in the presence of
serosally-added MCh (3×10!7 M), the results of this study demonstrate that these responses are
dependent upon the osmolyte used to elevate mucosal tonicity. The triphasic change in Isc
following the addition of hypertonic NaCl solution is very intriguing; however, the
electrophysiological basis of the first two phases, the rapid decrease followed by an increase,
could not be elucidated because these particular responses were inconsistent between and within
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animals. In response to MKH solution made hypertonic with either NaCl or D-mannitol, there
was always a slow, sustained decrease in Isc, indicating that this electrophysiological response is
the characteristic bioelectric response of the airway epithelium to elevated mucosal tonicity.
Since MKH solution made hypertonic with either added NaCl or D-mannitol elicited a
slow, sustained decrease in Isc, the effect of ion transport inhibitors on this particular response
was evaluated. This decrease in Isc following an elevation in mucosal tonicity may be explained
by the same mechanisms believed to account for hyperosmotic stress of the airways during dry
air hyperpnea (Figure 10; Anderson and Daviskas, 1999). Because elevated mucosal tonicity
would decrease the osmotic pressure of the ASL, water would exit the cell; thus, intracellular
Na+ and Cl! concentrations would increase. Consequently, this would decrease Na+ absorption
and increase Cl! secretion. A decrease in Na+ absorption and an increase in Cl! secretion would
decrease and increase the Isc respectively, and the net effect on Isc would be dependent upon
which ion transport process dominates. In addition, the effect on Isc elicited by elevated mucosal
tonicity is also dependent upon the paracellular pathway conductance. A previous study reported
that the decrease in Isc following elevated mucosal tonicity was due to a decrease in Na+
absorption. In fact, this same study also reported that Cl! secretion was not induced by elevated
mucosal tonicity (Willumsen et al., 1994). This explanation describing the decrease in Isc fits
with the effects of D-mannitol since it is membrane-impermeable; however, the effects of NaCl
are more complicated because it is membrane-semipermeable. In order to fully elucidate the
particular ion fluxes which are altered following exposure of the tracheal epithelium to elevated
mucosal tonicity, isotope flux studies are necessary.
The significant attenuation of the hypertonicity-induced UIsc by amiloride, regardless
of the osmolyte used to elevated tonicity, suggests that apical Na+ channels are involved in the
epithelial bioelectric response to elevated mucosal tonicity. In the presence of amiloride, the Isc
response to elevated mucosal tonicity is most likely reduced for two reasons. First, Na+ is unable
to leave the cell across the apical membrane in the presence of amiloride. Secondly, amiloride
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stimulates Cl! secretion (Boucher et al., 1982), which would offset any decrease in Isc by
hypertonic solution.
The significant, inhibitory effect of bumetanide on hypertonicity-induced UIsc, regardless
of the osmolyte used to elevate tonicity, suggests that basolateral Na+-K+-2Cl! cotransporters
along with apical Na+ channels are involved in the epithelial bioelectric response to elevated
mucosal tonicity. The reason bumetanide attenuates the UIsc elicited by elevated mucosal
tonicity is dependent upon the existence and activation of another basolateral Cl!-coupled
transporter when the Na+-K+-2Cl! cotransporter is inhibited. Two candidates include the Cl!HCO3! exchanger and the Na+-coupled Cl! transporter. In fact, the Na+-coupled Cl! transporter
is postulated to exist in the basolateral membranes of Cl! secretory epithelia
(Frizzell et al., 1979). How would the action of the Na+-coupled Cl! transporter, if it exists in
guinea-pig tracheal epithelium, offset the decrease in Isc elicited by elevated mucosal tonicity?
According to the model of hyperosmotic stress of the airways during dry air hyperpnea, not only
do the intracellular concentrations of Na+ and Cl! increase, but also the extracellular
concentrations of these ions in the submucosa (Figure 10) (Anderson and Daviskas, 1999) which
would tend to drive these ions into the overlying epithelial cell by means of the Na+-coupled Cl!
transporter if the Na+-K+-2Cl! cotransporter is inhibited by bumetanide. Na+ and Cl! would
begin to accumulate in the cell, and in order to obtain electrochemical equilibrium, they must be
extruded across either the apical or basolateral membranes. According to the model proposed by
Frizzell et al. (1979), Na+ is extruded from the cell by the action of the basolateral Na+-K+ATPase while Cl! is driven from the cell across the apical membrane. In the presence of
hypertonicity, the intracellular Cl! concentration is increased so any further increase would
accentuate its secretion across the apical membrane. This stimulation of Cl! secretion would
offset the decrease in Isc elicited by hypertonic solution. This scenario holds true only if another
Cl!-coupled transporter is activated following inhibition of the Na+-K+-2Cl! cotransporter.
Unlike amiloride and bumetanide, the effects of NPPB on hypertonicity-induced UIsc
was osmolyte dependent. In the presence of NPPB, hypertonic NaCl solution increased rather
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than decreased the Isc. Under basal conditions, NPPB will hyperpolarize the apical membrane;
therefore, it will consequently stimulate Na+ absorption and increase Isc. The addition of
hypertonic NaCl solution will increase the inward Na+ gradient, which, in all likelihood, will
potentiate Na+ influx when Cl! is elevated inside the cell by NPPB. This enormous inward Na+
flux will increase the Isc response in such a way that it overwhelms any Isc decrease evoked by
elevated mucosal tonicity. NPPB almost completely abolished the UIsc induced by hypertonic Dmannitol. Since NPPB did not have the same effect on UIsc elicited by hypertonic D-mannitol
and NaCl, this suggests that role of apical Cl! channels in the epithelial bioelectric response to
elevated mucosal tonicity is osmolyte dependent, and at this moment, unclear. The application
of hypertonic D-mannitol to the mucosal surface will drive Na+ across the apical membrane,
decreasing Isc; however, this decrease is almost completely abolished, meaning it must be
opposed by an increase in Isc by some other ion, namely Cl!. The only manner in which this can
occur is by movement of Cl! out of the cell across the basolateral membrane or through apical
Cl! channels which are insensitive to NPPB. Exit across the basolateral membrane could occur
through either the Na+-K+-2Cl! cotransporter or the Cl!-HCO3! exchanger and/or possibly the
Na+-coupled Cl! transporter if they exist in guinea-pig tracheal epithelium.
The lack of effect of iberiotoxin on UIsc induced by hypertonic solution suggests that
Ca2+-activated K+ channels have no apparent role in the epithelial bioelectric response to
elevated mucosal tonicity; however, this does not rule out the possibility of other K+ channels
being involved. Although the effects of ouabain, a Na+-K+-ATPase inhibitor, on UIsc changes
induced by hypertonic solution were examined in this study, the results were inconclusive since
ouabain completely abolished the Isc. A further characterization of the possible involvement of
the Na+-K+-ATPase in the epithelial bioelectric response to elevated mucosal tonicity is
impossible since its pharmacological inhibitor, ouabain, completely abolishes the baseline Isc.
When comparing the first and second epithelial bioelectric responses to hypertonic NaCl
or D-mannitol solution in the same tissue, the second response to NaCl, not D-mannitol, was
significantly less than the first; however, this effect was not as great as the effect of the tested
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inhibitors on reducing Isc. This indicates that the tissue desensitizes in response to hypertonic
NaCl solution and that some of the reduction in Isc seen with the inhibitors is partially due to
desensitization.
The overall goal of this study was to demonstrate that those ion channels involved in
hypertonicity-induced smooth muscle relaxation via EpDRF were also involved in the epithelial
bioelectric response to elevated tonicity, and if this was found to be the case, this would further
support the hypothesis that the synthesis, release, and/or effects of EpDRF are functionally
linked to epithelial electrical activity. Fedan et al. (1999) reported that apical Na+ and
Cl!channels were involved in EpDRF-induced smooth muscle relaxation; however, this study
has shown that apical Na+ channels and basolateral Na+-K+-2Cl! cotransporters are involved in
the epithelial bioelectric response to elevated mucosal tonicity while the role of apical
Cl!channels and basolateral Na+-K+-ATPases is unclear.
Because amiloride significantly attenuated hypertonicity-induced smooth muscle
relaxation via EpDRF and the epithelial bioelectric response to elevated mucosal tonicity, this
provides further evidence that apical Na+ channels are intimately involved in the synthesis,
release, and/or effects of EpDRF. The role of these channels in mediating EpDRF-induced
relaxation responses is unclear. Because the mechanisms by which eukaryotic cells sense
increases or decreases in extracellular tonicity are poorly understood (Cohen, 1997), it is possible
that these Na+ channels are in fact osmotic sensors which initiate EpDRF synthesis and/or
signaling by relaying extracellular changes in tonicity to the intracellular environment. If the
normal activity of these channels are interfered with by amiloride, it may alter their ability to
sense changes in tonicity and/or communicate these changes to the intracellular environment. It
is very unlikely that amiloride-sensitive Na+ channels are the only, possible osmotic sensors of
the airway epithelial cells given the fact that elevations in serosal tonicity also lead to the
synthesis, release, and/or effects of EpDRF (Fedan et al., 1999). It is possible that each epithelial
surface may have its only osmotic sensor. Because the Na+-K+-2Cl! cotransporter is also
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involved in the epithelial bioelectric response to elevated mucosal tonicity, the possibility exists
that this transporter is the osmotic sensor of the basolateral surface.
Fedan et al. (1999) reported that bumetanide produced a modest inhibition (p < 0.07) of
EpDRF-induced smooth muscle relaxation at added NaCl concentrations equal or greater than
150 mOsm; however, this study has shown that bumetanide attenuated UIsc changes evoked by
only 120 mOsm of added NaCl or D-mannitol. The inconsistency between the effects of
bumetanide on EpDRF-induced smooth muscle relaxation and hypertonicity-induced UIsc
suggests that the Na+-K+-2Cl! cotransporter is involved in the epithelial bioelectric response to
elevated hypertonicity but not appreciably involved in EpDRF-induced smooth muscle
relaxation. From this study, the relationship between the mechanical and bioelectric effects of
Cl! channel blockers on hypertonicity-induced smooth muscle relaxation and epithelial
bioelectric responses, respectively, cannot be determined. Fedan et al. (1999) used DIDS, a Cl!
channel blocker and Cl!-HCO3! exchanger inhibitor (Lamb et al., 2000), rather than NPPB, a
nonselective Cl! channel blocker, to come to the conclusion that apical Cl! channels are involved
in mediating EpDRF-induced smooth muscle relaxation. The effect seen with DIDS may have
nothing to do with its effect upon apical Cl! channels but everything to do with its effect upon
the Cl!-HCO3! exchanger. In order for further clarification of the role of Cl! channels and/or
transporters, the effect DIDS on UIsc and NPPB on EpDRF-induced smooth muscle relaxation,
respectively, will have to be examined. Finally, there is a discrepancy between the lack of effect
of iberiotoxin on the epithelial bioelectric response to elevated mucosal tonicity and its inhibitory
effect on the synthesis and/or release of EpDRF. Tamaoki et al. (1997) used iberiotoxin to
examine the basal synthesis and/or release of EpDRF, that is, they did not evoke the effects of
EpDRF by elevating mucosal or serosal tonicity. For further clarification of the possible
involvement of Ca2+-activated K+ channels in this response, the effect of iberiotoxin on EpDRFinduced smooth muscle relaxation should be examined by stimulating the effects of EpDRF with
hypertonic solution. If iberiotoxin fails to have any effect on EpDRF-induced smooth muscle
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relaxation elicited with hypertonic solution, this could suggest that the basal and stimulated
release of EpDRF are controlled by different mechanisms.
The mechanisms by which hypertonicity-induced changes in epithelial bioelectric activity
lead to the synthesis, release, and/or effects of EpDRF are unclear; however, the phenomenon of
electrical signals releasing autacoids is not unheard of in physiological systems. For example,
the release of EpDRF from the airway epithelium, due to altered epithelial electrical activity,
may be analogous to the release of ACh from nerve terminals following the propagation of an
action potential along the length of a neuron. It is possible that EpDRF, like ACh, is
prepackaged in vesicles and released from its cell of origin following a change in the potential
difference across the cell membrane.
There were two major points brought about following the conclusion of this study. First,
the basic physiological ion transport properties of guinea-pig tracheal epithelium need to be
further investigated since this study has shown, contrary to the accepted model, that guinea-pig
tracheal epithelium may be a Cl!secretory epithelium rather than a Na+ absorbing epithelium.
Secondly, these results demonstrate that the epithelial bioelectric response to elevated mucosal
tonicity is mediated by the actions of amiloride-sensitive Na+ channels and the bumetanidesensitive Na+-K+-2Cl! cotransporter while the role of apical Cl! channels and basolateral Na+K+-ATPases is unclear. Because amiloride attenuated hypertonicity-induced smooth muscle
relaxation via EpDRF (Fedan et al., 1999) and the epithelial bioelectric response to elevated
mucosal tonicity, apical Na+ channels appear to be heavily involved in the synthesis, release,
and/or effects of EpDRF.
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Lipopolysaccharide-Induced Alterations in Epithelial
Electrophysiology in Relation to Epithelium-Derived
Relaxing Factor and Airway Reactivity
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Objectives
Previous work has suggested that the synthesis, release, and/or effects of EpDRF are
functionally linked to the electrical activity of epithelial cells (Raeburn and Fedan, 1989; DortchCarnes, et al., 1999; Fedan et al., 1999); therefore, this study sought to determine what effects
alterations in epithelial ion transport had upon EpDRF-induced airway smooth muscle relaxation.
The hypothesis of this study was that alterations in epithelial ion transport were associated with
changes in EpDRF-induced smooth muscle relaxation since the two appear to be functionally
linked; therefore, any change in the bioelectric properties of the airway epithelium should
subsequently effect the synthesis, release, and/or effects of EpDRF. Because LPS-treatment (4
mg/kg, i.p.; 18 hr post-treatment) has been shown to alter the basal bioelectric properties of
guinea-pig tracheal epithelium (Johnston and Fedan, 1999), this model system was utilized to
examine what effect altered epithelial ion transport had upon EpDRF-induced smooth muscle
relaxation.
The hypothesis was tested through a variety of different experiments. First, tracheal
smooth muscle mechanical responses (contraction and relaxation) and epithelial bioelectric
responses (Vms) were measured in isolated, perfused trachea from saline (control)- and LPStreated guinea pigs. If it is found that LPS-treatment alters EpDRF-induced smooth muscle
relaxation, it will then be hypothesized that airway reactivity to contractile agonists in vitro and
in vivo will also be altered.

Materials and Methods
Animals
Specific, pathogen-free, male Dunkin-Hartley guinea pigs (Harlan Sprague Dawley, Inc.;
Indianapolis, IN; 405-700 g) were used during the course of this study. The guinea pigs were
housed in separate, actively ventilated, micro-isolator cages (Lab Products, Inc.; Seaford, DE)
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within a single room. The room within which these animals were housed were part of an 8800
ft2 modified barrier, animal care facility. Within this facility, the animals were acclimated to
their new environment prior to experimentation, given food and water ad libitum, and breathed
fresh air. All of the animals in the animal care facility, as well as the facility itself, were under
the supervision of a full-time veterinarian.
Throughout this study, the guinea pigs were sacrificed according to a standard protocol.
The animals were first anesthetized intraperitoneally (i.p.) with sodium pentobarbital (Veterinary
Laboratories, Inc.; Lenexa, KS; 65 mg/kg), and once it was determined that the animals were
unresponsive to any stimuli, they were exsanguinated by severing the abdominal aorta and
cutting the heart.
All of the experimental protocols in this study were approved by the Institutional Animal
Care and Use Committee (IACUC) while the facilities where the experimental protocols were
conducted were fully accredited by the Association for the Assessment and Accreditation of
Laboratory Animal Care (AAALAC) International. These facilities have been accredited by
AAALAC International since February 18, 1987.

In Vivo Saline- and Lipopolysaccharide-Treatments
Guinea pigs were injected i.p. with 4 mg/kg lipopolysaccharide (LPS) from Salmonella
typhimurium or a volume equivalent of 0.9 % sodium chloride irrigation, USP (saline, control;
Baxter Healthcare Corporation; Deerfield, IL). Eighteen hr after treatment, in vitro or in vivo
experiments were conducted.

Isolated, Perfused Trachea Apparatus
The isolated, perfused trachea apparatus (Figure 21) is a unique in vitro preparation
which is used to measure tracheal smooth muscle contractile and relaxant responses in response
to various pharmacological agents (Munakata et al., 1988; Fedan and Frazer, 1992).
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This preparation consisted of two separate, water-jacketed organ baths whose
temperature was maintained at 37oC. The 30 ml extraluminal (EL) or serosal bath and the 30 ml
intraluminal (IL) or mucosal bath were filled with MKH solution that was continuously gassed
with 95% O2-5% CO2. In order to remove the trachea from the guinea pig, the animal was
sacrificed as previously described. The trachea was exposed in vivo, a 4.2 cm segment excised,
placed in MKH solution gassed with 95% O2-5% CO2, and cleaned by removing extraneous
tissue. The trachea was then mounted on a stainless steel perfusion holder, stretched to its in situ
length, and placed into the EL bath containing gassed MKH solution. After attaching the
necessary tubing, the trachea was perfused, at a constant rate of 34 ml/min, with gassed,
recirculating MKH solution (37oC) from the separate IL bath. Since the tracheal smooth muscle
and epithelium were in direct contact with the gassed MKH solution in the EL and IL baths,
respectively, pharmacological agents added to the EL bath have direct access to the smooth
muscle while those agents added to the IL bath must first diffuse through the epithelium before
reaching the smooth muscle. This preparation, therefore, allowed one to study the degree to
which the epithelium can modulate airway reactivity.
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Figure 21. Isolated, perfused trachea apparatus. A 4.2 cm length of guinea-pig trachea, shownin
blue, is attached to a perfusion holder and placed in the extraluminal (EL) or serosal bath
containing modified Krebs-Henseleit (MKH) solution maintained at 37oC. Once all of the
necessary tubing is attached, the intraluminal (IL) or mucosal surface of the trachea is perfused at
a constant rate with recirculating MKH solution also maintained at 37oC. The red arrows
indicate the direction of fluid flow through the preparation. As explained in the text, this
preparation can measure contractile and relaxant responses of the tracheal smooth muscle
(illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.).
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Contractile and relaxant responses of the tracheal smooth muscle were measured as
changes in the inlet minus outlet pressure difference (UP; cm H2O) between the side holes of
two indwelling catheters which became inserted into the lumen upon mounting the trachea to the
holder (Figure 22). The proximal and distal ends of the trachea were attached with suture
(Deknatel, Inc.; Fall River, MA) around the inlet and outlet catheters, respectively. The inlet and
outlet catheters were connected by pressure lines to the positive and negative sides, respectively,
of a differential pressure transducer (Validyne Engineering Corp.; Northridge, CA). Because the
rate of fluid movement through the trachea was kept constant (34 ml/min), the UP responses
were representative of changes in tracheal cross-sectional area associated with contraction and
relaxation; therefore, an increase or decrease in UP was associated with smooth muscle
contraction and relaxation, respectively (Munakata et al., 1989). These responses were recorded
on a conventional strip chart recorder (Gould Instrument Systems; Valley View, OH). In all
instances, the transmural pressure was zeroed, and the preparations were equilibrated for 3 hr
before any experimental manipulations were initiated. During the equilibration period, however,
the MKH solution in both baths was changed every 15 min.
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Figure 22. Differential pressure measurement in the isolated, perfused trachea apparatus.
Contractile and relaxant responses of the tracheal smooth muscle are measured as changes in the
inlet minus outlet pressure difference (UP) between the side holes of the indwelling perfusion
holder catheters. The trachea is shown in blue, and the red arrows indicate the direction of fluid
flow through the trachea (illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.).
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Modified Isolated, Perfused Trachea Apparatus
Recent modifications to the isolated, perfused trachea apparatus now permit
transepithelial potential difference (Vms; Dortch-Carnes et al., 1999) to be measured
simultaneously with smooth muscle contractile and relaxant responses at the proximal and distal
ends of the trachea. The experimental setup of this preparation was unchanged from before
(Figure 21); however, modifications of the perfusion holder were made to measure epithelial
bioelectric responses. Because epithelial bioelectric responses were measured with this
preparation, a plastic perfusion holder, rather than a stainless steel one, was used. For the most
part, the plastic perfusion holder did not affect the manner in which smooth muscle mechanical
responses (UP) were measured; however, the flow rate in this preparation was kept constant at
22 ml/min instead of the 34 ml/min used with the stainless steel holder, which permitted
transmural pressure to be zeroed in the face of a greater fluid resistance of the plastic holder. A
schematic illustration of the modified perfusion holder is shown in Figure 23.
During the course of this study, Vms measurements were made at the proximal end of the
trachea, and the epithelium surrounding the opening of the inlet catheter was the point source for
the measurement of the Vms. Two silver/silver chloride calomel half cells, one designated as IL
or mucosal (Vm) and the other as EL or serosal (Vs), were used to measure the Vms. Each
calomel half cell was in contact with the fluid bathing either the EL or IL surfaces of the trachea
by means of Ussing voltage electrode cartridges [World Precision Instruments (WPI); Sarasota,
FL] filled with 3 M KCl in 4 % melted bacteriological agar. The Vms was equal to the sum of
Vm, Vs, and an offset potential. Before the trachea was mounted on the perfusion holder, any
potential difference between the electrodes, not exceeding ±2 mV, was dialed to zero
(Dortch-Carnes et al., 1999).
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Figure 23. Vms measurement in the modified isolated, perfused trachea apparatus. The Vms can
be measured at either the proximal or distal end of the trachea through the side hole of the
indwelling perfusion holder catheter; however, this study measured the Vms only at the proximal
end of the trachea. Again, the trachea is shown in blue and the red arrows indicate the direction
of fluid flow through the trachea. The negative sign (!
!) refers to the fact that the airway
epithelium generates a lumen-negative potential with respect to the positive (+), basolateral
surface (illustration produced by and courtesy of Jeffrey S. Fedan, Ph.D.).
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A two-channel DVC-1000 voltage/current clamp (WPI; Sarasota, FL) was used in the
measurement of tracheal Vms responses. The Vms was recorded continuously under open-circuit
conditions on a conventional strip chart recorder (Gould Instrument Systems; Valley View, OH).

In Vitro Elevated Tonicity Concentration-Response Curves
EpDRF release was stimulated by increasing the tonicity of the MKH solution perfusing
the IL surface of the trachea with either NaCl, KCl, D-mannitol, or urea. After obtaining a stable
contraction with extraluminally-added MCh (3×10!7 M; ~EC50 for contraction), concentrationresponse curves for relaxation were generated by adding the osmolytes in stepwise-increasing,
cumulative concentrations to the IL bath. Equiosmolar, rather than equimolar, concentrations of
the osmolytes were added to the IL bath. The relaxation responses were normalized as a
percentage of the MCh-induced contraction.
In addition, concentration-response curves for UVms were generated by adding NaCl in
stepwise-increasing, cumulative concentrations to the EL and/or IL baths in the presence and
absence of MCh. The EL and IL curves were obtained from each trachea, the IL curve first,
followed 90 min later by the EL curve.

In Vitro Effects of Agents on EpDRF-Induced Smooth Muscle Relaxation
During the course of this study, inhibitors of enzymes important to the synthesis of nitric
oxide and prostanoids were utilized to determine whether or not they affected EpDRF-induced
smooth muscle relaxation. Each inhibitor was added to the EL and IL baths 30 min prior to
inducing muscle tone with extraluminally-added MCh (3×10!7 M; ~EC50). When relaxation
concentration-response curves were generated, the effect of an inhibitor upon responses was
compared to the responses in control preparations where the inhibitor was absent.
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In Vitro Effects of Agents on the Basal Vms
In some experiments, the effects of indomethacin, NT-nitro-L-arginine methyl ester (LNAME), atropine, sodium nitroprusside, and amiloride on the basal Vms were determined.
Indomethacin, L-NAME, atropine, and sodium nitroprusside were added to the EL and IL baths
simultaneously while amiloride was only added to the IL bath.
The effect of LPS on the basal Vms was determined in tracheas from naive animals by
adding 10 µg/ml of LPS to the EL and IL baths simultaneously. An untreated, control
preparation was run in parallel as a time control.

In Vitro MCh Concentration-Response Curves
MCh concentration-response curves were generated by adding MCh in stepwiseincreasing, cumulative concentrations to the EL and IL baths. EL and IL MCh concentrationresponse curves were obtained from each trachea, the EL curve first, followed 90min later by the
IL curve, with washes every 15 min. The contractile responses to MCh were normalized as a
percentage of the maximum MCh-induced contraction.

Tracheal Epithelium Removal
In isolated, perfused trachea experiments requiring removal of the tracheal epithelium, a
trimmed, 6-cm segment of pipe cleaner (Fisher Scientific; Pittsburgh, PA) was slowly and
carefully inserted into the tracheal lumen and then withdrawn while rotating slowly
(Fedan and Frazer, 1992).

Pulmonary Function Measurements
A plethysmograph is used to measure lung volumes and pulmonary function parameters
in vivo. In this study, a two-chambered, whole-body plethysmograph (Figure 24) was used
(Buxco Electronics, Inc.; Sharon, CT).
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A conscious guinea pig was placed in the plethysmograph so that its head and thorax
were in the head and body chamber, respectively. In addition, two latex collars were placed
around the animal’s neck in order to restrain it. Besides restraining the animal, the collars form
an airtight seal between the two chambers. The guinea pig breathed fresh air through a port in
the head chamber, and administered agents entered the head chamber through a separate, aerosol
port. The head and thoracic chambers were equipped with identical wire screen
pneumotachographs and SEN1 differential pressure transducers. The differential pressure
transducers measured pressure changes within each chamber and were connected to an LS-20
noninvasive airway mechanics analyzer. The results were then logged and displayed on a
computer screen.

66

Figure 24. Two-chambered, whole-body plethysmograph. The two-chambered, whole-body
plethysmograph is used along with its associated equipment to measure in vivo pulmonary
function parameters and reactivity to inhaled, MCh aerosol. Reprinted from J Pharmacol
Toxicol Methods, Chong BTY, Agrawal DK, Romero FA and Townley RG, Measurement of
bronchoconstriction using whole-body plethysmograph: Comparison of freely moving versus
restrained guinea pigs, pp 163-168, 1998, with permission from Elsevier Science.
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The plethysmograph was capable of measuring ten pulmonary function parameters from
a single breath, but this study was only concerned with two: breathing frequency (BF) and
specific airway resistance (SRaw). The first parameter of interest, BF, was expressed as the
number of breaths per minute (BPM). The computer analyzes each breath with regard to four
exclusion criteria: (1) the minimum inspiratory time, (2) the maximum inspiratory time, (3) the
peak expiratory flow, and (4) the percent maximum deviation between the inspiratory and
expiratory volume. A breath must fall in the normal range of all four criteria in order to be
recorded (Lomask, 1996).
SRaw is the product of airway resistance and thoracic gas volume and is expressed in
cm H2O•s. SRaw is an indicator of airway resistance, and in mathematical terms, it can be
described by the following equation:
SRaw = tan2(Patm - 47)(1.36)(Ti/B)

Figure 25 illustrates the derivation of theta (2) which can also be expressed mathematically by
the following equation:
2 = B(UT)/Ti
UT is the delay time between the zero crossings of nasal and thoracic flows at the end of
inspiration. UT is computed in seconds and used to calculate 2, which is the phase shift
between the nasal and thoracic flows. The additional components of the SRaw equation are as
follows: (1) 1.36 is the conversion factor from mm Hg to cm H2O, (2) Patm is the barometric
pressure in mm Hg, and (3) Ti is the inspiratory time (Lomask, 1996).
Both SRaw and BF data were logged at 6 sec intervals with the mean of ten consecutive
averages taken as the measurement at each time point.
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In Vivo MCh Dose-Response Curves
The guinea pig was placed in the two-chambered, whole-body plethysmograph 24 hr
prior to generating an in vivo MCh concentration-response curve, and the animal was acclimated
to the chamber for 2 hr in air. This reduced the stress that the animal experienced when placed in
the plethysmograph a second time. On the second day, the animal was again placed in the
plethysmograph and acclimated in air for 20 min. During this 20 min period, SRaw and BF were
continuously recorded to get basal SRaw and BF values. Next, a saline aerosol vehicle was
delivered to the head chamber for 3 min, and at the end of this period, SRaw and BF data were
taken at 6 sec intervals for 3 min as the animl breathed air. After a 30 min resting period, the
lowest concentration of MCh aerosol was delivered to the head chamber for 3 min. Once the
aerosol delivery was stopped, SRaw and BF were again measured for 3 min as the animal
breathed air. After 30 min, SRaw and BF returned to their basal values, and the next higher
concentration of MCh was delivered to the chamber and the procedure was repeated with
increasing MCh concentrations. Unlike in vitro experiments, a full in vivo dose-response curve
was impossible to generate because the animals cannot tolerate dyspnea accompanying a
maximum response; therefore, ED50's and maximum responses could not be determined. MCh
concentrations ranging between 0.0316 and 3.16 mg/ml were delivered.
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Figure 25. Definition of theta. A schematic illustration of guinea-pig head (nasal) and body
(thoracic) airflow during inspiration and expiration as recorded by the data collection system
associated with the two-chambered, whole-body plethysmograph. Since thoracic airflow
precedes nasal airflow at the zero crossing following inspiration, UT (delay time) can be
calculated, which is subsequently used to calculate theta (2). Reprinted from Lomask K (1996)
BioSystem XA User's Manual, Version 0.9.3, Buxco Electronics, Inc., Sharon, CT with
permission from Buxco Electronics, Inc.
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The MCh PC200, the provocative MCh concentration producing a two-fold increase in basal
SRaw, was calculated by linear interpolation of graphed data. All aerosols were generated using
an Ultra Neb 99 DeVilbiss nebulizer (DeVilbiss Co.; Somerset, PA) containing 5 ml of solution.
When examining the effects of saline- and LPS-treatments on airway reactivity to inhaled
MCh aerosol, a standard protocol was followed. Naive animals were acclimated on day 1 and
the same animals exposed to MCh aerosols on day 2. These animals were then treated with
saline or LPS, and 18 hr post-treatment, airway reactivity to inhaled MCh was determined. In all
instances, each animal served as its own control since reactivity to MCh was determined before
and after saline- and LPS-treatments.

In Vivo Administration of L-NAME
To test the possibility that inhaled L-NAME aerosol may affect airway reactivity to
inhaled MCh in saline- and LPS-treated animals, guinea pigs were exposed to L-NAME aerosol
(1.2 mM) for 5 min prior to the delivery of each MCh concentration. Two MCh concentrationresponse curves were generated in both saline- and LPS-treated animals, the first in the absence
and the second after treatment with L-NAME.

Histological Examination of Guinea-Pig Airways
Following anesthesia and exsanguination, trachea and lungs from saline- and LPS-treated
animals were inflated with 15-20 ml of 10% buffered formalin phosphate (Fisher Scientific;
Pittsburgh, PA) and removed en bloc. Sections of the trachea as well as the azygous, left, right
apical, right cardiac, and right diaphragmatic lobes of the lung were then embedded with
paraplast-plus paraffin before being cut into 5 µm slices with a microtome. Individual sections
were then placed on glass microscope slides where they were stained according to Harris’
hematoxylin and eosin procedure. Following the conclusion of section staining, section mounting

71

was completed by placing a cover slip over the tissue section. Finally, the slides were examined
in a “blind” fashion under the light microscope by a veterinary pathologist.

Solutions and Reagents
The MKH solution contained (mM): NaCl (113.0), KCl (4.8), CaCl2 (2.5), KH2PO4
(1.2), MgSO4 (1.2), NaHCO3 (25.0), and glucose (5.7). The MKH solution was continuously
gassed with 95% O2-5% CO2 and maintained at 37oC and a pH of 7.4. In addition, the
osmolarity of the MKH solution was 281.2±0.6 mOsm (n = 5; Osmette A Automatic
Osmometer, Precision Systems, Inc.; Sudbury, MA).
All chemical reagents used during the course of this study were purchased from Sigma
Chemical Co. (St. Louis, MO) and dissolved in saline unless otherwise noted. Indomethacin was
prepared in 100 mM sodium carbonate.

Analysis of Results
The data obtained from in vitro concentration-response curves examining EpDRFinduced smooth muscle relaxation were normalized as a percent of the MCh-induced contraction
while in vitro UP MCh concentration-response curves were normalized as a percent of the
maximum response. Data normalization was necessary in these instances to avoid large
variability among UP values (Fedan and Frazer, 1992). Since UP is dependent upon the fifth
power of the radius of the trachea, small differences in the internal diameter of the trachea can
lead to large variability among UP values (Munakata et al., 1989). Geometric EC50 values were
derived from the least squares analysis of a sigmoidal curve fit (Sigma Plot®). When comparing
EC50 values statistically, normally-distributed EC50 values were used. The EC50's and maximum
responses were then analyzed using either the paired or nonpaired Student’s t test, the MannWhitney rank sum test, or one-way repeated measures analysis of variance (ANOVA), as
appropriate. For concentration-response curves examining UVms, the EC50's and maximum
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responses were derived and statistically compared in the same manner as described for the UP
responses.
When examining the effect of agents on the Vms, the data were statistically analyzed
using either the paired or nonpaired Student’s t test or the Mann-Whitney rank sum test, as
appropriate.
For in vivo airway reactivity studies, pre-treatment and post-treatment BF, SRaw, and
MCh PC200 values among saline- and LPS-treated animals were statistically compared using the
paired or nonpaired Student’s t test or Mann-Whitney rank sum test, as appropriate. The effect
of L-NAME on MCh PC200 values among saline- and LPS-treated animals was compared using
the paired or nonpaired Student’s t test, as appropriate.
All of the results, except where noted, were expressed as the mean ± S.E.M. (standard
error of the mean) where n is the number of separate experiments. In every experiment, p < 0.05
was considered significant.
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Results
Effect of LPS-treatment on basal Vms in isolated, perfused trachea
LPS-treatment increased the basal Vms in isolated, perfused trachea. The basal Vms was
!14.6±1.2 mV and !28.3±1.9 mV for the saline- and LPS-treated groups, respectively (Figure
26).

Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation in
isolated, perfused trachea
In order to test the hypothesis that LPS-induced alterations in epithelial ion transport
were associated with perturbations in EpDRF-induced smooth muscle relaxation, smooth muscle
reactivity to EpDRF was measured in isolated, perfused tracheas from saline- and LPS-treated
guinea pigs. EpDRF-induced smooth muscle relaxation was stimulated by increasing the tonicity
of the IL MKH solution with four different osmolytes (NaCl, D-mannitol, urea, and KCl)
following contraction of the smooth muscle with extraluminally-applied MCh (3×10!7 M;
~EC50). Figures 27-29 and Table 1 summarize the results of this study. When NaCl and Dmannitol were used to increase the tonicity of the IL bath, EpDRF-induced smooth muscle
relaxation was potentiated in tracheas from LPS-treated animals (Figure 27). When urea was
used, there was no difference in the maximum relaxation responses between the two treatment
groups; however, there was a small, but significant decrease in smooth muscle reactivity to
EpDRF in the LPS-treated group, as demonstrated by a rightward shift of the concentrationresponse curve (Figure 28).
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Figure 26. Effect of LPS-treatment on the basal Vms in isolated, perfused trachea. Basal Vms
values were obtained from tracheas removed from saline- and LPS-treated animals 18 hr posttreatment. Saline- and LPS-treated, n = 20. *p < 0.05 compared to saline as determined by a
nonpaired Student’s t test.
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Figure 27. Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation elicited with
IL MKH solution made hypertonic with added (A) NaCl or (B) D-mannitol. The curves were
obtained from tracheas removed from saline- and LPS-treated animals 18 hr post-treatment. The
preparations were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before NaCl
or D-mannitol were added in stepwise-increasing, cumulative concentrations to the IL bath.
EpDRF-induced smooth muscle relaxation was potentiated in tracheas from LPS-treated animals
when NaCl or D-mannitol were used to evoke EpDRF release. The osmolyte concentrations
shown in the abscissa of the figures refer to the osmolar concentrations of osmolyte added to the
IL MKH solution. Equiosmolar, rather than equimolar, concentrations of NaCl and D-mannitol
were added to the IL bath. For NaCl the osmolarity is twice the molarity and for D-mannitol the
osmolarity is the same as the molarity. Saline- and LPS-treated, n = 8 for NaCl and n = 6 for Dmannitol. *p < 0.05 compared to saline as determined by a nonpaired Student’s t test.
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Figure 28. Effect of LPS-treatment on EpDRF-induced smooth muscle relaxation elicited with
IL MKH solution made hypertonic with added urea. The curves were obtained from tracheas
removed from saline- and LPS-treated animals 18 hr post-treatment. The preparations were
contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before urea was added in
stepwise-increasing, cumulative concentrations to the IL bath. LPS-treatment did not affect the
maximum relaxation response; however, it caused a small, but significant decrease in smooth
muscle reactivity to EpDRF, as demonstrated by an increase in the EC50 for relaxation. (A) and
(B) are the same data but expressed in a different manner to illustrate the significant difference in
EC50 values between the treatment groups which is clearly seen in (B). The data in (B) is
expressed as a percentage of the maximum relaxation response. The urea concentrations shown
in the abscissa of the figures refer to the osmolar concentrations of urea added to the IL MKH
solution. For urea the osmolarity is the same as the molarity. Saline- and LPS-treated, n = 6.
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Figure 29. Lack of effect of LPS-treatment on EpDRF-induced smooth muscle relaxation
elicited with IL MKH solution made hypertonic with added KCl. The curves were obtained from
tracheas removed from saline- and LPS-treated animals 18 hr post-treatment. The preparations
were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before KCl was added in
stepwise-increasing, cumulative concentrations to the IL bath. Neither the maximum relaxation
response nor the EC50 were affected by LPS-treatment when KCl was used to evoke EpDRF
release and subsequent smooth muscle relaxation. The KCl concentrations shown in the abscissa
of the figure refer to the osmolar concentrations of KCl added to the IL MKH solution. For KCl
the osmolarity is twice the molarity. Saline- and LPS-treated, n = 4.
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TABLE 1
Effect of LPS-treatment on in vitro airway reactivity to
EpDRF in isolated, perfused trachea
Treatment (n)
NaCl
Saline (8)
LPS (8)

EC50 (mOsm)a
(95% C.I.)

Maximum Response
(% of MCh)b

11.4
(8.2-15.8)
10.4
(8.4-12.8)

78.2±6.2
113.3±9.5c

D-Mannitol
Saline (6)
LPS (6)

15.2
(8.2-28.2)
15.9
(11.1-22.7)

86.1±4.9
109.7±8.5c

Urea
Saline (6)
LPS (6)

10.7
(9.0-12.9)
23.3c
(20.2-26.9)

110.3±7.0

16.8
(9.4-30.2)
14.0
(10.6-18.2)

110.2±15.0

122.3±7.5

KCl
Saline (4)
LPS (4)

99.0±7.2

The tracheas were removed from the animals 18 hr post-treatment. aValues refer to mOsm of
osmolyte added to the intraluminal MKH solution. bRelaxation responses in cm H2O were
normalized as a percentage of the extraluminal MCh (3×10!7 M; ~EC50)-induced contraction.
c
Significantly greater than saline-treated controls.
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Finally, when KCl was used to evoke EpDRF release and subsequent smooth muscle relaxation,
there was no difference in the concentration-response curves among the saline- and LPS-treated
groups (Figure 29).

Effect of indomethacin and L-NAME on EpDRF-induced smooth muscle
relaxation in isolated, perfused trachea from saline- and LPS-treated guinea
pigs
Because LPS is known to up-regulate both inducible cyclooxygenase and nitric oxide
synthase (Okamoto et al., 1998), the effect of indomethacin, a cyclooxygenase inhibitor, and LNAME, a nitric oxide synthase inhibitor, on EpDRF-induced smooth muscle relaxation was
tested. This was done to rule out the possible contribution of prostaglandins and NO to the
potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment. Neither
indomethacin nor L-NAME affected EpDRF-induced smooth muscle relaxation when NaCl was
used to elevate tonicity in isolated, perfused trachea from saline- and LPS-treated guinea pigs
(Figures 30 and 31).

Effect of LPS-treatment on the epithelial bioelectric events associated with
EpDRF-induced smooth muscle relaxation
A previous study has shown that EpDRF-induced smooth muscle relaxation, elicited by
hypertonicity, was associated with epithelial bioelectric events, namely a depolarization of the
Vms (Dortch-Carnes et al., 1999). The current study has shown that LPS-treatment potentiated
EpDRF-induced smooth muscle relaxation when NaCl and D-mannitol were used to elicit
EpDRF release; therefore, according to the hypothesis, the epithelial bioelectric events
associated with increased EpDRF-induced smooth muscle relaxation should also be potentiated
following LPS-treatment.
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Figure 30. Lack of effect of extraluminally- and intraluminally-applied indomethacin (3×10!6
M) on EpDRF-mediated relaxation responses elicited with IL MKH solution made hypertonic
with added NaCl. The curves were obtained from tracheas removed from (A) saline- and (B)
LPS-treated animals 18 hr post-treatment. Indomethacin was present for 30 min prior to
contracting the tracheal smooth muscle with extraluminally-applied MCh (3×10!7 M; ~EC50) and
initiating EpDRF-induced smooth muscle relaxation by adding NaCl in stepwise-increasing,
cumulative concentrations to the IL bath. Saline- and LPS-treated, n = 4.
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Figure 31. Lack of effect of extraluminally- and intraluminally-applied L-NAME (10!4 M) on
EpDRF-mediated relaxation responses elicited with IL MKH solution made hypertonic with
added NaCl. The curves were obtained from tracheas removed from (A) saline- and (B) LPStreated animals 18 hr post-treatment. L-NAME was present for 30 min prior to contracting the
tracheal smooth muscle with extraluminally-applied MCh (3×10!7 M; ~EC50) and initiating
EpDRF-induced smooth muscle relaxation by adding NaCl in stepwise-increasing, cumulative
concentrations to the IL bath. Saline- and LPS-treated, n = 4.
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NaCl concentration-response curves with respect to UVms were generated from isolated,
perfused tracheas from saline- and LPS-treated animals in the presence of extraluminally-applied
3×10!7 M MCh (Figure 32). For an easy comparison of the relationship between hypertonicityinduced epithelial depolarization and smooth muscle relaxation, depolarization and relaxation
concentration-response curves were plotted alongside each other as a percentage of the
maximum depolarization or relaxation, respectively (Figure 33). In tracheas from LPS-treated
animals, the IL addition of NaCl significantly increased epithelial depolarization and EpDRFinduced smooth muscle relaxation compared to the saline-treated controls; however, the Vms of
each treatment group eventually depolarized to the same level (Figure 32 and Table 2). In both
treatment groups, the EC50 for depolarization was significantly greater than the EC50 for EpDRFinduced smooth muscle relaxation (Figure 33 and Table 2).
Besides examining epithelial bioelectric reactivity to NaCl in the presence of
extraluminally-applied MCh (3×10!7 M), this study also examined epithelial bioelectric
reactivity to NaCl in the absence of MCh (Figures 34 and 35 and Table 3). The addition of
hypertonic NaCl to the EL and IL baths depolarized the Vms in a concentration-dependent
manner. In both treatment groups, extraluminally-applied NaCl was more potent than
intraluminally-applied NaCl. When comparing responses between the two treatment groups, the
IL EC50 for depolar-ization was significantly greater in the LPS-treated group compared to the
saline-treated group. Finally, extraluminally- and intraluminally-applied NaCl depolarized the
Vms to a greater extent in the LPS-treated group; however, it did not reach statistical significance,
except for one concentration added intraluminally (Figure 35).
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Figure 32. Effect of LPS-treatment on epithelial bioelectric reactivity to hypertonic NaCl in the
presence of extraluminally-added MCh (3×10!7 M). The curves were obtained from tracheas
removed from saline- and LPS-treated animals 18 hr post-treatment. MCh (3×10!7 M) was
added to the EL bath before NaCl was added in stepwise-increasing, cumulative concentrations
to the IL bath. (A) The mV change in the Vms evoked by the addition of IL NaCl. LPS-treatment
significantly increased the degree of depolarization while the EC50's were unaffected. (B) These
are data from the same experiments in (A); however, they are expressed in a different manner.
These plots show the actual Vms following the addition of IL NaCl. In both treatment groups,
intraluminally-applied NaCl eventually depolarized the Vms to the same level. Saline- and LPStreated, n = 4. *p < 0.05 compared to saline-treated as determined by a nonpaired Student’s t
test.
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Figure 33. Effect of LPS-treatment on the relationship between EpDRF-induced smooth muscle
relaxation and epithelial depolarization elicited by hypertonic NaCl. The curves were obtained
from tracheas removed from saline- and LPS-treated animals 18 hr post-treatment. The
preparations were contracted with extraluminally-applied MCh (3×10!7 M; ~EC50) before NaCl
was added in stepwise-increasing, cumulative concentrations to the IL bath. This figure
illustrates that the EC50's for depolarization are significantly greater than the EC50's for relaxation
in both treatment groups. Saline- and LPS-treated for relaxation, n = 8 and saline- and LPStreated for depolarization, n = 4.
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TABLE 2
Relationship between in vitro smooth muscle relaxation and epithelial depolarization
in isolated, perfused trachea from saline- and LPS-treated guinea pigs

Treatment
Saline
LPS

EC50 (mOsm)a
(95% C.I.)
Relaxation
Depolarization
b
(% of MCh)
UVms (mV)c
11.4
121.6d
(8.2-15.8)
(75.0-197.2)
10.4
183.6e
(8.4-12.8)
(120.2-280.4)

Maximum Response
Relaxation
Depolarization
b
(% of MCh)
UVms (mV)c
78.2±6.2
15.3±0.5
113.3±9.5f

38.0±4.1f

The tracheas were removed from the animals 18 hr post-treatment. aValues refer to mOsm of
NaCl added to the intraluminal MKH solution. bRelaxation responses in cm H2O were
normalized as a percentage of the extraluminal MCh (3×10!7 M; ~EC50)-induced contraction;
saline- and LPS- treated, n = 8. cValues refer to the change of the Vms after the administration of
extraluminal MCh (3×10!7 M); saline- and LPS-treated, n = 4. dSignificantly greater than saline
(relaxation). eSignificantly greater than LPS (relaxation). fSignificantly greater than salinetreated controls.
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Figure 34. Effect of LPS-treatment on epithelial bioelectric reactivity to extraluminally- and
intraluminally-applied NaCl in the absence of MCh (a within-treatment group comparison). EL
and IL NaCl concentration-response curves were obtained from tracheas removed from (A)
saline- and (B) LPS-treated animals 18 hr post-treatment. NaCl was added in stepwiseincreasing, cumulative concentrations to the EL and IL baths. In both treatment groups,
extraluminally-applied NaCl was more potent. The arrows refer to the fact that the next highest
concentration of intraluminally-applied NaCl reversed the depolarization, or in other words,
hyperpolarized the Vms. In addition, because of the size of the EL bath and the limits of
solubility of NaCl, only 843.4 mOsm of NaCl could be added. Saline-treated, n = 7 and LPStreated, n = 6.
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Figure 35. Effect of LPS-treatment on epithelial bioelectric reactivity to (A) extraluminally- and
(B) intraluminally-applied NaCl in the absence of MCh (a between-treatment group comparison).
This is the same data shown in Figure 34 but in a different manner. EL and IL NaCl
concentration-response curves were obtained from tracheas removed from saline- and LPStreated animals 18 hr post-treatment. NaCl was added in stepwise-increasing, cumulative
concentrations to the EL and IL baths. NaCl depolarized the Vms to a greater extent in the LPStreated group; however, it did not reach statistical significance, except for one concentration
added intraluminally. The arrows refer to the fact that the next highest concentration of
intraluminally-applied NaCl reversed the depolarization, or in other words, hyperpolarized the
Vms. In addition, because of the size of the EL bath and the limits of solubility of NaCl, only
843.4 mOsm of NaCl could be added. Saline-treated, n = 7 and LPS-treated, n = 6. *p < 0.05
compared to saline-treated as determined by a nonpaired Student’s t test.
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TABLE 3
Effect of LPS-treatment on in vitro epithelial bioelectric reactivity to
hypertonic NaCl in isolated, perfused trachea
EC50 (mOsm)a
(95% C.I.)
Treatment (n)
Saline (7)
LPS (6)

EL

IL

68.2
(57.6-81.0)
88.6
(73.0-107.2)

157.4b
(95.0-261.0)
313.4c,d
(283.0-347.0)

EL, extraluminal; IL, intraluminal. The tracheas were removed from the animals 18 hr posttreatment. aValues refer to mOsm of NaCl added to the extraluminal or intraluminal MKH
solution. bSignificantly greater than saline (EL). cSignificantly greater than LPS (EL).
d
Significantly greater than saline (IL).
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Effects of indomethacin and L-NAME on LPS-induced alterations of the basal
Vms in isolated, perfused trachea
In order to elucidate the mechanism underlying the increase in the basal Vms following
LPS-treatment, the effect of indomethacin (3×10!6 M) and L-NAME (10!4 M) on the basal Vms
was examined. Both indomethacin and L-NAME were chosen because LPS up-regulates their
targets, cyclooxygenase and nitric oxide synthase (Okamoto et al., 1998) whose products,
prostaglandins and NO, respectively, have been shown to stimulate Cl! secretion (Tamaoki et al.,
1992; Tamai and Gaginella, 1993).
Indomethacin depolarized the Vms in both treatment groups (Figure 36), but significantly
more so in the LPS-treated group: +3.1±0.5 mV and +5.5±0.7 mV for the saline- and LPStreated groups, respectively (p < 0.05).
L-NAME slightly hyperpolarized the Vms in both treatment groups (Figure 37); however,
there was no significant difference between the magnitude of the hyperpolarization among the
saline- and LPS-treated groups.
Because L-NAME has been shown to possess muscarinic receptor antagonist properties
(Buxton et al., 1993), the effect of atropine (10!6 M), a muscarinic receptor antagonist, on the
basal Vms was characterized to determine if the small effect of L-NAME was due to the
inhibition of nitric oxide synthesis or muscarinic receptor blockade.
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Figure 36. Effect of indomethacin on the basal Vms of isolated, perfused trachea from salineand LPS-treated animals. The tracheas were removed from saline- and LPS-treated animals 18
hr post-treatment. Following a 3 hr equilibration period, indomethacin (3×10!6 M) was
simultaneously added to the EL and IL baths. (A) The actual mV change in the basal Vms
evoked by the addition of indomethacin. The depolarizing effect of indomethacin was
significantly greater in the LPS-treated group. (B) In the presence of indomethacin, the Vms was
significantly decreased in both treatment groups. Saline- and LPS-treated, n = 5. *p < 0.05
compared to saline-treated as determined by a nonpaired Student’s t test. †p < 0.05 compared to
saline-treated (!Indomethacin) as determined by a paired Student’s t test. ††p < 0.05 compared
to saline-treated (!Indomethacin) as determined by a nonpaired Student’s t test. †††p < 0.05
compared to LPS-treated (!Indomethacin) as determined by a paired Student’s t test.
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Figure 37. Effect of L-NAME on the basal Vms of isolated, perfused trachea from saline- and
LPS-treated animals. The tracheas were removed from saline- and LPS-treated animals 18 hr
post-treatment. Following a 3 hr equilibration period, L-NAME (10!4 M) was added
simultaneously to the EL and IL baths. (A) The actual mV change in the Vms evoked by the
addition of L-NAME. There was no difference in the hyperpolarizing effect of L-NAME
between the treatment groups. (B) There was no difference in the Vms before and after the
addition of L-NAME within each treatment group. Saline- and LPS-treated, n = 4. *p < 0.05
compared to saline-treated (!L-NAME) as determined by a nonpaired Student’s t test. †p < 0.05
compared to saline-treated (+L-NAME) as determined by a nonpaired Student’s t test.
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The effect of atropine on the basal Vms in isolated, perfused trachea from saline- and LPStreated animals is shown in Figure 38. Atropine’s effect was variable in both treatment groups.
Atropine initiated either a depolarization or a hyperpolarization of the Vms which did not exceed
±2 mV.
Since atropine did not clarify the effects of nitric oxide and its possible contribution to
the basal Vms, the effect of sodium nitroprusside (SNP), a nitric oxide donor, on the basal Vms of
isolated, perfused trachea from saline- and LPS-treated animals was determined (Figure 39).
SNP (10!6 M) caused a very small depolarization of the basal Vms; however, there was no
difference in the magnitude of the depolarization among the treatment groups.

Effect of amiloride on LPS-induced alterations of the basal Vms in isolated,
perfused trachea
Since the effects of indomethacin and L-NAME gave little insight into the mechanism
responsible for the increased basal Vms in tracheas from LPS-treated animals, the Na+ channel
blocker, amiloride, was used (Figure 40). Amiloride was chosen because its target plays an
important role in epithelial ion transport (Figure 6). The application of amiloride (3×10!5 M) to
the IL surface of isolated, perfused tracheas from saline- and LPS-treated animals depolarized
the Vms, but significantly more so in the LPS-treated group. After the addition of amiloride,
there was no longer any difference between the Vms’s among the saline- and LPS-treated groups.
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Figure 38. Effect of atropine on the basal Vms of isolated, perfused trachea from (A) saline- and
(B) LPS-treated animals. The tracheas were removed from saline- and LPS-treated animals 18
hr post-treatment. Following a 3 hr equilibration period, atropine (10!6 M) was added
simultaneously to the EL and IL baths. In both groups, atropine had variable effects, sometimes
depolarizing and other times hyperpolarizing. Since there was no consistent effect, the raw data
from four individual experiments was plotted and an average value shown underneath each
graph. Saline- and LPS-treated, n = 4.
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Figure 39. Effect of SNP on the basal Vms of isolated, perfused trachea from saline- and LPStreated animals. The tracheas were removed from saline- and LPS-treated animals 18 hr posttreatment. Following a 3 hr equilibration period, SNP (10!6 M) was added to the EL and IL
baths. (A) The actual mV change in the basal Vms evoked by the addition of SNP. There was no
significant difference between the degree to which SNP depolarized the Vms among the treatment
groups. (B) There was no difference in the Vms before and after the addition of SNP within each
treatment group. Saline- and LPS-treated, n = 3. *p < 0.05 compared to saline-treated (!SNP)
as determined by a nonpaired Student’s t test. †p < 0.05 compared to saline-treated (+SNP) as
determined by a nonpaired Student’s t test.
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Figure 40. Effect of amiloride on the basal Vms of isolated, perfused trachea from saline- and
LPS-treated animals. The tracheas were removed from saline- and LPS-treated animals 18 hr
post-treatment. Following a 3 hr equilibration period, amiloride (3×10!5 M) was added to the IL
bath. (A) The actual mV change in the basal Vms evoked by the addition of amiloride. The
depolarizing effect of amiloride was significantly greater in the LPS-treated group. (B)
Amiloride significantly altered the Vms in both treatment groups. After the IL application of
amiloride, there was no longer a difference between the Vms’s among the two groups. Salineand LPS-treated, n = 5. *p < 0.05 compared to saline-treated as determined by a nonpaired
Student’s t test. †p < 0.05 compared to saline-treated (!Amiloride) as determined by a paired
Student’s t test. ††p < 0.05 compared to saline-treated (!Amiloride) as determined by a
nonpaired Student’s t test. †††p < 0.05 compared to LPS-treated (!Amiloride) as determined by
a paired Student’s t test.
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Effect of the in vitro addition of LPS on the basal Vms of isolated, perfused
trachea from naive animals
Because this study has shown that in vivo LPS-treatment (4 mg/kg, i.p; 18 hr posttreatment) significantly hyperpolarized the basal Vms (Figure 26), it was of interest to investigate
whether or not the in vitro application of LPS to the organ bath did the same. The addition of
LPS (10 µg/ml) to the EL and IL surfaces of isolated, perfused trachea from naive guinea pigs
caused a nearly significant (p = 0.055) hyperpolarization of the basal Vms when compared to the
control preparation to which nothing was added (Figure 41). In the untreated, control
preparation, the reported UVms was due to a slight hyperpolarization of the Vms over time which
is inherent to the tissue. In addition, LPS caused a significant change in the basal Vms when
compared to the UVms in the absence of LPS.

Effect of LPS-treatment on in vitro airway reactivity to MCh in epitheliumintact and -denuded isolated, perfused trachea
Previous studies have shown that increases and decreases in EpDRF-induced smooth
muscle relaxation were associated with alterations in in vitro and in vivo airway reactivity to
MCh (Lawrence et al., 1996; Fedan et al., 2000). In this study LPS-treatment was shown to alter
EpDRF-induced smooth muscle relaxation; therefore, it is hypothesized that in vitro and/or in
vivo airway reactivity to MCh should be altered in accordance with the aforementioned studies.
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Figure 41. Effect of the in vitro addition of LPS on the basal Vms of isolated, perfused trachea
from naive animals. Following a 3 hr equilibration period, LPS (10 µg/ml) was simultaneously
added to the EL and IL baths. (A) The hyperpolarizing effect of LPS on the basal Vms reached a
nearly significant level when compared to the untreated, control preparation. The reported UVms
for the untreated, control preparation was due to a slight hyperpolarization of the Vms over time
which was inherent to the tissue. (B) There was a significant difference between the Vms’s
before and after the addition of LPS. t = 0 hr refers to the time immediately before the start of
the control- or LPS-treatment period. t = x hr refers to the length of the control- or LPStreatment period which was dependent upon the time required for the response to LPS to
equilibrate, and the length of this period was variable between tracheas. Control- and LPStreated, n = 5. †p = 0.055 compared to control-treated as determined by a nonpaired Student’s t
test. *p < 0.05 compared to !LPS as determined by a paired Student’s t test.
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In epithelium-intact tracheas, there was no difference in reactivity to extraluminally- and
intraluminally-applied MCh between the two treatment groups; however, the tracheas from both
treatment groups were more sensitive to extraluminally-applied MCh (Figure 42A, Table 4). In
addition, there was no difference in the IL/EL maximum response ratio between the saline- and
LPS-treated groups.
In epithelium-denuded tracheas, the differences between EL and IL reactivity to MCh
were abolished, and the IL/EL maximum response ratio approached unity (Figure 42B, Table 5).
In addition, there was no difference in reactivity to extraluminally- and intraluminally-applied
MCh in epithelium-denuded tracheas from saline- and LPS-treated animals.

Effect of LPS-treatment on tracheal epithelial bioelectric reactivity
to MCh in isolated, perfused trachea
Although LPS-treatment did not affect in vitro smooth muscle reactivity to MCh in
epithelium-intact and -denuded isolated, perfused tracheas, it had a profound effect upon tracheal
epithelial bioelectric reactivity to MCh.
In tracheas from both saline- and LPS-treated animals, extraluminally-applied MCh
produced a biphasic concentration-response curve (Figure 43 and Table 6). At MCh
concentrations less than 10!6 M, the Vms hyperpolarized while at MCh concentrations greater
than 10!6 M, the Vms depolarized. The EC50's and maximum responses for hyperpolarization
were smaller and larger, respectively, in the LPS-treated group; however, the MCh EC50's and
maximum responses for depolarization were not different. The IL application of MCh also
generated biphasic electrical concentration-response curves in both treatment groups
(hyperpolarizing at MCh concentrations less than 10!3 M and depolarizing at MCh
concentrations greater than 10!3 M; Figure 43 and Table 6).
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Figure 42. Lack of effect of LPS-treatment on tracheal smooth muscle reactivity to
extraluminally- and intraluminally-applied MCh in (A) epithelium-intact and (B) -denuded
isolated, perfused trachea. EL and IL MCh concentration-response curves were obtained from
tracheas removed from saline- and LPS-treated animals 18 hr post-treatment. In epitheliumintact tracheas from saline- and LPS-treated animals, extraluminally-applied MCh was more
potent. Removal of the epithelium abolished the difference between reactivity to extraluminallyand intraluminally-applied MCh. Saline- and LPS-treated, n = 6 for epithelium-intact and n = 4
for epithelium-denuded.
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TABLE 4
Effect of LPS-treatment on in vitro airway reactivity to
MCh in epithelium-intact, isolated, perfused trachea
EC50 (M)
(95% C.I.)

Maximum Response
UP (cm H2O)
EL
IL

Treatment (n)

EL

IL

Saline (6)

1.9×10!7
(1.4-2.5)
2.1×10!7
(1.7-2.4)

3.7×10!4b
(1.5-9.1)
3.2×10!4d
(1.8-5.8)

LPS (6)

IL/EL Maximum
Response Ratioa

10.7±1.5

8.4±1.1c

0.78±0.03

6.6±0.9

4.7±0.9e

0.70±0.12

EL, extraluminal; IL, intraluminal. The tracheas were removed from the animals 18 hr posttreatment. aThe IL/EL maximum response ratio is used to gauge the modulatory effect of the
epithelium on the EL and IL maximum contractile responses. In the absence of the epithelium,
the ratio is unity while it becomes less than unity in the presence of the epithelium. As the
modulatory effect of the epithelium becomes more inhibitory, the ratio becomes smaller (Fedan
and Frazer, 1992; Fedan et al., 2000). bSignificantly greater than saline (EL). cSignificantly less
than saline (EL). dSignificantly greater than LPS (EL). eSignificantly less than LPS (EL).
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TABLE 5
Effect of LPS-treatment on in vitro airway reactivity to
MCh in epithelium-denuded, isolated, perfused trachea
EC50 (M)
(95% C.I.)

Maximum Response
UP (cm H2O)
EL
IL

Treatment (n)

EL

IL

Saline (4)

2.1×10!6
(0.8-5.2)
1.1×10!6
(0.5-2.2)

7.7×10!6
(2.0-30.0)
1.5×10!6
(0.8-2.8)

LPS (4)

IL/EL Maximum
Response Ratioa

3.8±0.7

3.5±0.6

0.97±0.12

3.9±0.4

3.5±0.3

1.00±0.06

EL, extraluminal; IL, intraluminal. The tracheas were removed from the animals 18 hr posttreatment. aThe IL/EL maximum response ratio is used to gauge the modulatory effect of the
epithelium on the EL and IL maximum contractile responses. In the absence of the epithelium,
the ratio is unity while it becomes less than unity in the presence of the epithelium. As the
modulatory effect of the epithelium becomes more inhibitory, the ratio becomes smaller (Fedan
and Frazer, 1992; Fedan et al., 2000).
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In the case of intraluminally-applied MCh, the maximum hyperpolarization response was greater
in the LPS-treated group with respect to the saline-treated controls while there was no difference
in the depolarization responses among the two treatment groups.

Effect of LPS-treatment on in vivo pulmonary function and airway reactivity
to MCh
Besides investigating whether or not LPS-treatment altered in vitro airway reactivity to
MCh in the isolated, perfused trachea, this study also investigated whether or not LPS-treatment
altered in vivo airway reactivity to inhaled, MCh aerosol.
The post-treatment saline BF was slightly, but significantly, less than the pre-treatment
value; however, there were no other differences between the pre- or post-treatment SRaw or BF
values within each treatment group (Figure 44).
Eighteen hr following saline-treatment, the animals’ reactivity to inhaled, MCh aerosol
increased which was demonstrated by a decrease in the MCh PC200 (Figure 45 and Table 7). On
the other hand, LPS-treatment failed to produce any changes in airway reactivity to MCh when
the LPS pre-and post-treatment groups were compared; however, when comparing the saline and
LPS post-treatment groups to allow for the increase in reactivity in the saline-treated group, the
LPS-treated animals were 3-fold hyporeactive to the effects of inhaled MCh as determined by a
comparison of their MCh PC200 values (Table 7).
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Figure 43. Effect of LPS-treatment on epithelial bioelectric reactivity to (A) extraluminally- and
(B) intraluminally-applied MCh in isolated, perfused trachea. EL and IL MCh concentrationresponse curves were obtained from tracheas removed from saline- and LPS-treated animals 18
hr post-treatment. The results were expressed as changes in the transepithelial potential
difference (UVms). Positive values refer to depolarization of the Vms while negative values refer
to hyperpolarization of the Vms. In both groups, extraluminally-applied MCh was more potent.
Saline-treated, n = 7 and LPS-treated, n = 6. *p < 0.05 compared to saline-treated controls as
determined by a nonpaired Student’s t test.
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TABLE 6
Effect of LPS-treatment on in vitro epithelial bioelectric reactivity to
MCh in isolated, perfused trachea
EC50 (M)
(95% C.I.)
Treatment (n)

EL

IL

6.2×10!8
(2.9-13.0)
4.2×10!9c
(1.6-11.0)

9.8×10!6b
(2.1-45.0)
2.7×10!6d
(1.8-5.9)

2.6×10!6
(1.5-4.3)
1.9×10!6
(1.0-3.7)

7.6×10!2b
(2.3-23.0)
2.8×10!2d
(0.7-10.0)

Maximum Response
UVms (mV)a
EL
IL

Hyperpolarization
Saline (7)
LPS (6)

!0.9±0.3

!1.6±0.3

!3.0±0.7b

!5.3±1.6e

2.3±0.6

4.0±1.1

4.8±1.6

5.0±1.1

Depolarization
Saline (7)
LPS (6)

EL, extraluminal; IL, intraluminal. The tracheas were removed from the animals 18 hr posttreatment. aValues refer to the change in the Vms. bSignificantly greater than saline (EL).
c
Significantly less than saline (EL). dSignificantly greater than LPS (EL). eSignificantly greater
than saline (IL).
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Figure 44. Effect of saline- and LPS-treatments on post-treatment basal (A) specific airway
resistance (SRaw) and (B) breathing frequency (BF). Eighteen hr following saline- and LPStreatments, basal SRaw and BF were measured. There was a slight, but significant, decrease in
the saline post-treatment BF when compared to the pre-treatment value. There were no other
differences between the pre- and post-treatment values. Saline- and LPS-treated, n = 6. *p <
0.05 compared to saline pre-treatment as determined by a paired Student’s t test.
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Figure 45. Effect of (A) saline- and (B) LPS-treatments on in vivo airway reactivity to inhaled
MCh aerosol. Eighteen hr post-treatment, (A) the reactivity of the saline-treated animals to
inhaled, MCh aerosol increased while (B) LPS-treatment had no significant effect on airway
reactivity. When comparing the saline- and LPS-treated groups to allow for the increase in
reactivity of the saline-treated group, the LPS-treated animals were hyporeactive to the effects of
inhaled MCh. Saline- and LPS-treated, n = 6.
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TABLE 7
Effect of saline- and LPS-treatments on in vivo airway
reactivity to inhaled MCh
MCh PC200 (mg/ml)
(95% C.I.)
Treatment (n)

Pre-treatment

Post-treatment

Saline (6)

0.17
(0.11-0.27)
0.18
(0.13-0.25)

0.08a
(0.05-0.14)
0.26b
(0.08-0.79)

LPS (6)

a

Significantly less than saline (pre-treatment). bSignificantly greater than saline (post-treatment).
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Effect of L-NAME on in vivo airway reactivity to MCh in saline- and LPStreated animals
In order to determine if an acquired NO component contributed to the in vivo airway
hyporeactivity of the LPS-treated animals, the effect of an L-NAME aerosol on in vivo airway
reactivity to MCh was determined in saline-and LPS-treated animals. Prior to the generation of
in vivo MCh concentration-response curves in the presence of L-NAME, the LPS-treated animals
were again found to be hyporeactive to the effects of inhaled MCh as demonstrated by a
comparison of MCh PC200 values from saline- and LPS-treated animals (Figure 46 and Table 8).
The administration of L-NAME prior to MCh had no effect upon airway reactivity in either the
saline- or LPS-treated animals.

Histological Examination of Guinea-Pig Airways Following LPS-Treatment
Since L-NAME failed to provide any clues to the mechanism underlying LPS-induced in
vivo airway hyporeactivity to MCh, this study then examined the effects of LPS-treatment on the
microscopic structure of various regions of the guinea-pig respiratory tract. This was done to
determine if LPS-treatment altered the physical structure of the airways in such a way as to limit
access of MCh to the airway smooth muscle (i.e., excessive mucus secretion, epithelial and
basement membrane hyperplasia and/or hypertrophy, etc.). Histological sections of the distal
trachea as well as the azygous, left, right apical, right cardiac, and right diaphragmatic lobes of
the lung from saline- and LPS-treated animals were examined. The sections from both treatment
groups were indistinguishable from one another, at least at the level of the light microscope.
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Figure 46. Lack of effect of L-NAME on in vivo airway reactivity to inhaled MCh aerosol in
(A) saline- and (B) LPS-treated guinea pigs. Eighteen hr post-treatment, L-NAME did not alter
airway reactivity to MCh in either treatment group. Saline- and LPS-treated, n = 4.
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TABLE 8
Effect of L-NAME on in vivo airway reactivity to
inhaled MCh in saline- and LPS-treated guinea pigs
MCh PC200 (mg/ml)
(95% C.I.)
Treatment (n)

!L-NAME

+L-NAME

Saline (4)

0.07
(0.06-0.10)
0.78a
(0.31-1.97)

0.01
(0.00-0.94)
0.40
(0.11-1.45)

LPS (4)

a

Significantly greater than saline (!L-NAME).
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Representative sections of the distal trachea and left lobe of the lung from saline- and LPStreated animals are shown in Figure 47A-F. The bronchial and tracheal epithelium as well as the
alveolar sacs remained structurally intact within each group. Finally, in both treatment groups, a
few inflammatory cells, namely eosinophils and neutrophils, could be seen infiltrating the
airways in some regions of the respiratory tract which were examined (data not shown).
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Figure 47. Histological sections of guinea-pig airways following saline- and LPS-treatments.
Representative Harris’ hematoxylin-eosin stained histological sections from saline (A, C, and E)and LPS (B, D, and F)-treated animals made 18 hr post-treatment. A thorough examination of
histological sections from saline- and LPS-treated animals showed that LPS-treatment did not
alter airway appearance or structure, at least at the level of the light microscope. A and B are
40× sections of distal trachea, C and D are 10× sections of bronchi, and E and F are 20× sections
of the alveolar regions from saline- and LPS-treated animals, respectively. Sections of the
bronchi and alveolar regions were taken from the left lobe of the lung. The measurement bars
(50, 200, and 100 µm) found in B, D, and F also pertain to their respective counterpart in A, C,
and E. These results are representative of eight different experiments from each treatment group.
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Discussion
There are three general conclusions which can be drawn from the results of this study.
First, the effects of EpDRF on the airway smooth muscle are associated with changes in the
electrical activity of the airway epithelium following LPS-treatment; however, these changes in
the effects of EpDRF are dependent upon the osmolyte used to elicit EpDRF release. Secondly,
epithelial depolarization does not always precede EpDRF-induced smooth muscle relaxation,
suggesting that EpDRF release is not always dependent on epithelial depolarization. Finally,
LPS-induced in vivo airway hyporeactivity to inhaled, MCh aerosol may be due, at least in part,
to an increase in the actions of EpDRF.
Both in vivo and in vitro LPS-treatment significantly hyperpolarized the basal Vms of
isolated, perfused trachea. To our knowledge, there have been very few studies examining the
effect of LPS on ion channel and/or transporter function; however, those studies which have
examined this phenomenon aid in the explanation of our results. In rat tail artery smooth muscle
cells, LPS increased the inward flux of Ca2+ ions through voltage-sensitive Ca2+ channels
(Wilkinson et al., 1996) while two other, separate studies reported that LPS increased the
conductance of Ca2+-activated K+ channels in vascular smooth muscle cells
(Miyoshi and Nakaya, 1994; Hoang et al., 1997). In our system, LPS or one of its mediators
may be increasing epithelial cell Ca2+ influx which could activate Ca2+-activated K+ channels
found on the basolateral surface of the airway epithelium (Clarke and Boucher, 1993). It is
intriguing to note that Ca2+-activated K+ channels have been shown to be involved in the
synthesis and/or release of EpDRF (Tamaoki et al., 1997), and their activation by LPS or one of
its many mediators may account for the alterations in EpDRF-induced smooth muscle relaxation
following LPS-treatment.
The alteration of EpDRF-induced smooth muscle relaxation following LPS-treatment
was dependent upon the osmolyte used to elevate IL tonicity, suggesting that the synthesis,
release, and/or effects of EpDRF are osmolyte-dependent, at least after LPS-treatment. It is
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difficult to reconcile these results with the fact that EpDRF-induced smooth muscle relaxation is
initiated regardless of the osmolyte used to elevate EL or IL tonicity
(Munakata et al., 1988; Fedan et al., 1999). One study has examined the potency of different
osmolytes to elicit EpDRF-induced smooth muscle relaxation. This study reported that NaCl and
KCl were equipotent in their ability to evoke EpDRF-induced smooth muscle relaxation;
however, no other agents were examined (Fedan et al., 1999). The differences among the
osmolytes used in the present study could be due to their ability or inability to interact with
specific epithelial ion channels and/or transporters, namely apical Na+ and Cl! channels, which
seem to be involved in EpDRF-induced smooth muscle relaxation (Fedan et al., 1999). Dmannitol is membrane-impermeable so it would be unable to pass through any ion channel
and/or transporter while urea is freely, membrane-permeable. On the other hand, both NaCl and
KCl can enter the cell through their respective ion channels and/or transporters. In addition, this
study showed that LPS-treatment altered the basal bioelectric properties of the epithelium which
could further modify EpDRF-induced smooth muscle relaxation in response to these osmolytes if
a specific ion channel and/or transporter involved in these relaxation responses were altered
following LPS-treatment. It is of interest to note that a previous study examined the effects of
NaCl, mannitol, and urea on isolated, human bronchial strips, and they reported that hypertonic
NaCl and mannitol initiated bronchoconstriction while urea did not (Jongejan et al., 1990). As a
side note, the contractile responses elicited by these osmolytes may be attributed to species
differences or more importantly to the fact that one cannot selectively add pharmacological
agents to either the serosal or mucosal surfaces of strip preparations. Although our study looked
at EpDRF-induced smooth muscle relaxation elicited by these agents, our study and that of
Jongejan et al. (1990) demonstrated that hypertonic NaCl and D-mannitol behave in a similar
manner regardless of the endpoint, contraction or relaxation, examined. In our study, NaCl and
D-mannitol seem to be working by a similar mechanism while urea and KCl act by a different
mechanism from each other as well as from NaCl and D-mannitol following LPS-treatment.
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We investigated whether the potentiation of EpDRF-induced smooth muscle relaxation,
elicited by NaCl, following LPS-treatment was due to an acquired NO and/or prostanoid
component because both NO and certain prostanoids are known smooth muscle relaxants
(Folkerts and Nijkamp, 1998). In addition, LPS can up-regulate inducible nitric oxide synthase as
well as potentiate the smooth muscle relaxant effects of some prostanoids in guinea pigs
(Stein et al., 1996; Myers et al., 1999). Both L-NAME and indomethacin, inhibitors of nitric
oxide synthase and cyclooxygenase, respectively, failed to have any effect upon EpDRF-induced
smooth muscle relaxation in tracheas from saline- and LPS-treated animals. This further
supports the conclusion that EpDRF is neither NO nor a prostanoid and that the potentiation of
EpDRF-induced smooth muscle relaxation following LPS-treatment was not due to an acquired
NO or prostanoid component.
The potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment
was also associated with a potentiation of the epithelial bioelectric events, depolarization of the
Vms, preceding EpDRF-induced smooth muscle relaxation when NaCl was used to elevate IL
tonicity. These results further strengthen the hypothesis that the two events are functionally
linked. Both hypertonicity-induced smooth muscle relaxation and epithelial depolarization were
potentiated following LPS-treatment; however, in both treatment groups, the epithelium more
readily released EpDRF than depolarized in response to elevated mucosal tonicity. The
epithelium can release EpDRF, as demonstrated by smooth muscle relaxation, when as little as
0.84 mOsm of NaCl was added to the IL surface of the trachea; however, the Vms did not
depolarize in response to hypertonicity until approximately 8.44 mOsm of added NaCl. If
epithelial depolarization in response to hypertonicity signaled the release of EpDRF
(Dortch-Carnes et al., 1999), we would have expected the epithelium to depolarize prior to every
relaxation response; however, this was clearly not the case. Because of this discrepancy, it is
tempting to speculate that two events are taking place. At low concentrations of hypertonicity,
EpDRF release is independent of epithelial depolarization, a situation analogous to
pharmacomechanical coupling. As EpDRF is released in response to higher concentrations of
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hypertonicity, epithelial depolarization may be a necessary component to signal the release of
greater quantities of EpDRF, a situation analogous to electromechanical coupling.
Alternatively, transepithelial depolarization may be quite, simply a coincident,
epiphenomenon occurring in parallel with another signal (i.e., change in intracellular pH) that is
more sensitive to osmolarity changes. It is quite possible that changes in intracellular pH, and
not transepithelial depolarization, in response to elevated mucosal or serosal tonicity is the signal
for the synthesis, release, and/or effects of EpDRF. This is a potential avenue of further
investigation given the fact that exposure of cells to hyperosmotic solution causes cell
alkalinization (Miyata et al., 2000). In addition, the Na+ channel blocker, amiloride, and the
Cl!channel blocker, DIDS, which attenuate EpDRF-induced smooth muscle relaxation, are also
capable of inhibiting the Na+-H+ exchanger and the Cl!-HCO3! exchanger (Kreydiyyeh, 2000;
Lamb et al., 2000); respectively. The actions of these pharmacological inhibitors on their
respective targets would, without a doubt, profoundly influence intracellular pH.
This study also examined epithelial bioelectric reactivity to hypertonic NaCl in tracheas
from saline- and LPS-treated animals. These experiments were done in the absence of MCh
since smooth muscle contraction was not a necessary component of these experiments. In both
treatment groups, the epithelium depolarized in response to extraluminally- and intraluminallyapplied NaCl with the EL surface of the trachea being more sensitive to hypertonicity. This was
in contrast to another study examining the effect of hypertonicity on airway epithelial bioelectric
responses, in which cultured, human nasal epithelial cells depolarized only when hypertonic
mannitol was added to the apical surface of the epithelium (Willumsen et al., 1994). This
discrepancy may be attributed to species or regional differences in ion transport
(Boucher et al., 1980). Tracheas from LPS-treated animals were also less sensitive to the effects
of intraluminally-applied NaCl than those from saline-treated animals. Because the basal Vms in
tracheas from LPS-treated animals was significantly more hyperpolarized, it may be more
difficult to depolarize the Vms or the ion channels and/or transporters affected by hypertonicity
could be less sensitive to the effect of IL hypertonicity following LPS-treatment. Overall, these
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results demonstrate that the EL and IL surfaces of the trachea can function as an osmotic sensor,
with the EL surface being more sensitive. In addition, LPS-treatment alters the ability of the IL
surface to act as an osmotic sensor.
This study investigated the mechanism(s) behind the hyperpolarization of the Vms
following LPS-treatment by examining the effect of various pharmacological agents on the Vms.
Because LPS is known to up-regulate inducible nitric oxide synthase and cyclooxygenase, the
effect of their inhibitors on the basal Vms was examined. The small hyperpolarization of the Vms
by L-NAME in both treatment groups was not consistent with the reported effects of NO on ion
transport. In rat colon and human airway epithelial cells, NO stimulated Cl! secretion
(Tamai and Gaginella, 1993; Kamosinska et al., 1997). If NO stimulates Cl! secretion in our
system, L-NAME, by virtue of its ability to inhibit NO synthesis, should have depolarized the
Vms which was clearly not the case. Sodium nitroprusside, a NO donor, depolarized the Vms,
which was not consistent with a previous report demonstrating its ability to stimulate Cl!
secretion (Tamai and Gaginella, 1993). Our results, however, were internally consistent. Since
L-NAME hyperpolarized the Vms in our system, we would have expected a NO donor such as
sodium nitroprusside to depolarize the Vms. From both of these experiments, however, we can
conclude that NO makes an insignificant contribution to the generation of the Vms in tracheas
from either saline- or LPS-treated animals.
Because L-NAME has muscarinic antagonist properties (Buxton et al., 1993), we
investigated the effects of atropine, a nonspecific muscarinic receptor antagonist, on the basal
Vms in both treatment groups. The variable effects of atropine on the Vms observed in this study
were not consistent with another study which reported that atropine profoundly and rapidly
depolarized the Vms of rabbit trachea in vivo (Tamaoki et al., 1996). The variable effects of
atropine seen in this study could have resulted from the antagonism of different muscarinic
receptor subtypes, some of which may be more prevalent in one animal than another. This is a
reasonable conclusion given the fact that this study has shown that at least two populations of
muscarinic receptor subtypes exist in the guinea-pig tracheal epithelium which are capable of
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initiating opposite electrophysiological effects. The fact that atropine does have an
electrophysiological effect suggests that the nerves endings embedded in the airway wall are
tonically releasing ACh, which exerts its effect by binding to epithelial muscarinic receptors.
From our results with atropine, the true effect of L-NAME cannot be deciphered; however, a
more rigorous, future study should use equieffective concentrations of atropine and L-NAME
with respect to their muscarinic antagonist properties.
Unlike L-NAME, the electrophysiological effects of indomethacin reported in this study
were consistent with other studies in the literature. Two prostaglandins in particular, D2 and E2,
have been shown to stimulate Cl! secretion in several unrelated species
(Tamaoki et al., 1992a,b; Saunders et al., 1993; Bourke et al., 1995). Indomethacin depolarized
the Vms in both treatment groups, but significantly more so in the LPS-treated group. The
depolarizing effects of indomethacin were consistent with an inhibition of prostanoid-stimulated
Cl! secretion. The fact that indomethacin depolarized the Vms to a greater extent in the LPStreated group suggests that prostanoids contribute more to the generation of the basal Vms
following LPS-treatment and/or their effects were potentiated by changes in their receptor or
post-receptor signaling. In addition, this suggests that prostanoid-stimulated Cl! secretion may
contribute to the significant hyperpolarization of the Vms after LPS treatment.
The addition of amiloride to the IL surface of the trachea abolished the difference
between the Vms’s among the two treatment groups. This strongly suggests that the
hyperpolarization of the Vms following LPS-treatment was due to an increase in amiloridesensitive Na+ transport or Na+ transport in general. An increase in Na+ removal from the lumen,
via these channels, would generate a more negative Vms. Because the airway epithelium consists
of numerous ion channels and transporters, alterations in any of them (Figure 6) could explain
changes in the Vms following LPS-treatment. For example, an increase in the number and/or
activity of the Na+-K+-ATPase would increase amiloride-sensitive Na+ transport and
subsequently hyperpolarize the Vms. More systematic experiments which would take advantage
of patch clamping and transepithelial resistance and Isc measurements, and other ion channel and
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transporter inhibitors would be necessary to determine the mechanism responsible for LPSinduced hyperpolarization of the Vms. These results with amiloride also impact on the possible
mechanism(s) underlying the potentiation of EpDRF-induced smooth muscle relaxation
following LPS-treatment. If amiloride-sensitive Na+channels increase in number and/or activity
following LPS-treatment, this may potentiate EpDRF-induced smooth muscle relaxation
inasmuch as their inhibition significantly attenuates this response (Fedan et al., 1999).
The potentiation of EpDRF-induced smooth muscle relaxation following LPS-treatment
was associated with in vivo airway hyporeactivity to inhaled, MCh aerosol while no differences
in in vitro airway reactivity to MCh existed in isolated, perfused tracheas from saline- and LPStreated animals. Over the years, there have been several, inconsistent reports concerning the
effect of LPS-treatment on in vitro and in vivo guinea-pig airway reactivity. In vivo, some
studies have reported hyperreactivity (Oosterhout et al., 1991), hyporeactivity
(Folkerts et al., 1988), and no change (Fedan et al., 1995) in guinea-pig airway reactivity to
contractile agonists. The same can be said for in vitro airway reactivity as well. Again, some
studies have reported hyperreactivity to contractile agonists (ACh, histamine, arecoline)
(Folkerts et al., 1989; Yamawaki et al., 1990; Oosterhout et al., 1991), hyporeactivity
(Folkerts et al., 1988), and finally, others have shown no change (Fedan et al., 1995) in in vitro
guinea-pig airway reactivity. In our study, there were no differences in airway reactivity to MCh
in epithelium-intact and -denuded isolated, perfused tracheas. This is consistent with a previous
study in our laboratory (Fedan et al., 1995) even though the 18 hr post-treatment time point was
not examined. In vivo, LPS-treated guinea pigs were hyporeactive to the effects of inhaled, MCh
aerosol. This is not consistent with the earlier, published reports from our laboratory, but again
the 18 hr post-treatment time point was not examined which may account for the difference
(Fedan et al., 1995). An acquired NO component does not seem to be responsible for the
hyporeactivity to MCh following LPS-treatment in our study since inhaled, L-NAME aerosol
was without effect on in vivo airway reactivity to MCh in LPS-treated animals.
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In the previous study reporting in vivo airway hyporeactivity to histamine following LPStreatment (Folkerts et al., 1988), the airways of these guinea pigs were infiltrated with large
numbers of neutrophils and monocytes; however, there were no signs of pulmonary
inflammation following LPS-treatment in our study. This was probably due to the fact that the
guinea pigs in the previous study were exposed to LPS by inhalation and examined 24 hr posttreatment while our animals were given LPS i.p. and examined 18 hr post-treatment. The lack of
pulmonary inflammation in our LPS-treated guinea pigs suggests that changes in airway
reactivity are not necessarily accompanied by airway inflammation. The airway hyporeactivity
following LPS-treatment does not seem to be due to an acquired NO component or alterations in
the physical structure of the airways but may be due, at least in part, to an increase in the actions
of EpDRF. In vivo changes in airway reactivity did not manifest themselves in vitro which
suggests that the mechanism responsible for in vivo hyporeactivity to MCh did not involve the
trachea or was lost in vitro.
This is not the first time that alterations in the actions of EpDRF have been accompanied
by changes in in vivo and/or in vitro airway reactivity. For example, exposure to ozone causes a
decrease in the actions of EpDRF which is associated with in vivo and in vitro airway
hyperreactivity to MCh (Fedan et al., 2000). In addition, sensitization and challenge of guinea
pigs with ovalbumin potentiates EpDRF-induced smooth muscle relaxation which is
accompanied by in vitro airway hyporeactivity to MCh, but paradoxically, these animals are
hyperreactive to MCh in vivo (Lawrence et al., 1996). Now, with the addition of our study, there
are at least three instances in which changes in the actions of EpDRF are associated with in vivo
and/or in vitro alterations in airway reactivity to MCh, suggesting a functional relationship
between the two.
Although LPS-treatment did not have an effect upon in vitro airway smooth muscle
reactivity to MCh, it did have a profound effect upon in vitro epithelial bioelectric reactivity to
MCh. Biphasic concentration-response curves were generated in response to the EL- and ILapplication of MCh in both treatment groups. Our results were consistent with the variable
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electrophysiological effects produced by MCh in guinea-pig nasal epithelium (Suzuki et al.,
1999). Suzuki et al. (1999) reported that MCh produced triphasic Isc responses: a transient
increase followed by a small decrease and then finally a sustained increased. The authors
concluded that these changes were brought about by alterations in Cl! secretion and amiloridesensitive Na+ transport (Suzuki et al., 1999). MCh, by binding to either, M1, M3, or M5
muscarinic receptors increases cytosolic Ca 2+ by coupling Gq-proteins (Janssen et al., 1998).
Ca2+ in turn is capable of activating Ca2+-activated Cl! channels and/or Ca2+-activated K+
channels (Somlyo and Somlyo, 1994) which could subsequently alter the Vms. In addition, the
activation of M2 and M4 muscarinic receptors can open nonselective cation channels and inhibit
current flow through Ca2+ channels and Ca2+-activated K+ channels by coupling Gi-coupled
proteins (Roux et al., 1998). The activation of more than one channel was most likely
responsible for these biphasic electrical responses, and it is not certain which muscarinic receptor
subtypes were initiating these responses. M1, M2, and M3 muscarinic receptors have been
localized in guinea-pig lung (Mak and Barnes, 1990), and in the future it may be useful to repeat
these experiments in the presence of selective, muscarinic receptor antagonists. The muscarinic
receptors which were mediating these responses seem to be localized to the basolateral surface of
the epithelium since MCh was more potent when added to the EL surface of the trachea. Thus,
there seem to be two types of muscarinic epithelial receptors which promote opposite electrical
responses in the guinea-pig tracheal epithelium. The high affinity receptor initiates
hyperpolarization while the low affinity receptor mediates depolarization, and LPS-treatment
seems to selectively alter the function of the high affinity receptor.
Since LPS was used as a tool to alter the basal bioelectric properties of guinea-pig
tracheal epithelium, the results of this study have implications with respect to certain
pathophysiological conditions in which LPS is involved, such as sepsis, ARDS, as well as gramnegative pulmonary infections. Our study has shown that LPS-treatment alters the actions of
EpDRF on the airway smooth muscle, and this may potentially be happening under a variety of
LPS-induced disease states. At present, EpDRF’s only known function is to relax the airway
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smooth muscle; however, it may be an important mediator of other unknown, physiological
functions. That is, these other potential functions of EpDRF may be altered in such a way by
LPS that it contributes to the disease process. EpDRF may, when present at high or low levels,
be directly toxic to various cell types such that it inhibits their normal function or enhances the
release of toxic substances from cells. Conversely, high or low levels of EpDRF may protect
cells from the insulting effects of LPS in such a way as to prevent further damage.
In conclusion, the results of this study suggest that the effects of EpDRF on the airway
smooth muscle are associated with changes in the electrical activity of the airway epithelium;
however, there is not always a direct correlation between the two events. In addition, this study
has shown that perturbations in the effects of EpDRF are associated with changes in airway
reactivity, demonstrating that EpDRF exerts a powerful, modulatory influence on airway smooth
muscle tone.
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Conclusions
The initial reports by Raeburn and Fedan (1989), Dortch-Carnes et al. (1999), and Fedan
et al. (1999), suggesting that the synthesis, release, and/or effects of EpDRF were functionally
linked to the electrical activity of the airway epithelium, have been confirmed by the further
characterization of the airway epithelial bioelectric mechanisms associated with the effects of
EpDRF in this study.
Fedan et al. (1999) previously reported that apical Na+ channels are involved in
hypertonicity-induced smooth muscle relaxation via EpDRF, and this study has shown that these
channels are also involved in the epithelial bioelectric response to elevated mucosal tonicity.
These data suggest that the mechanical and bioelectric events are functionally linked; however,
the exact role of these channels in mediating these responses is unclear. Despite the fact that
inhibitors of basolateral Na+-K+-2Cl! cotransporters, basolateral Na+-K+-ATPases, and apical Cl!
channels altered the response to elevated mucosal tonicity, their effects were different, in some
respects, from their actions on EpDRF-induced smooth muscle relaxation, which makes their
overall role in these two responses difficult to discern.
This study has also demonstrated that perturbations in the basal electrical activity of the
epithelium following LPS-treatment are associated with alterations in EpDRF-induced smooth
muscle relaxation and its associated bioelectric events as well as airway reactivity. This further
supports the notion that the synthesis, release, and/or effects of EpDRF are linked to the
electrical activity of the epithelium. Interestingly, the results seen with LPS have reinforced the
importance of amiloride-sensitive Na+ channels in mediating EpDRF-induced smooth muscle
relaxation since LPS-induced changes in epithelial electrophysiology appear to be due alterations
in these Na+ channels. At the most fundamental level, apical Na+ channels may control airway
reactivity by modulating the synthesis, release, and/or effects of EpDRF.
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Future Directions
The two, separate studies contained within this project have provided the groundwork for
a more thorough investigation of the airway epithelial bioelectric mechanisms associated with
the effects of EpDRF in guinea-pig isolated trachea. In fact, this study has left many loose ends
which could be tied up with future experiments.
First, the effects of other hypertonic solutions (i.e., KCl, sucrose, urea, etc.), on epithelial
bioelectric responses could be examined to determine if the epithelial response to hypertonic
challenge is osmolyte dependent. In addition, the effects of ion channel and transporter
inhibitors on the epithelium’s bioelectric response to these hypertonic solutions could also be
investigated for similar reasons. In addition, these experiments could be repeated with LPStreated tissue to determine how this would influence the epithelial bioelectric responses to
hypertonic solution.
Since it appears that alterations in amiloride-sensitive Na+ channels play a significant role
in the hyperpolarization of the Vms following LPS-treatment, it would be interesting to examine
these channels at the molecular level. Channel protein or mRNA levels may change after LPStreatment which could be examined by Western and Northern blotting, respectively. In addition,
channel kinetics could be investigated through patch clamping. The effect of amiloride and the
other ion channel and transporter inhibitors on LPS-induced alterations in EpDRF-induced
smooth muscle relaxation could also be investigated. Finally, it would be interesting to see if
epithelial depolarization is potentiated following LPS-treatment in response to the IL-application
of D-mannitol, urea, and KCl, which could shed more light on the relationship between epithelial
depolarization and the degree of EpDRF-induced smooth muscle relaxation.
Although it was not a major focus of this study, it would be extremely interesting to
distinguish which epithelial muscarinic receptor subtypes were responsible for the biphasic
electrical responses to MCh, not only in saline-treated animals but also in those treated with LPS.
The use of selective, muscarinic receptor antagonists could give insight into the receptor
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subtypes involved. In addition, it would be of interest to distinguish why LPS-treatment only
affects the bioelectric reactivity of some muscarinic receptor subtypes and not others. This could
be accomplished through an examination of receptor binding, coupling, expression, etc.
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